{"meta":{"query_hash":"3c17a53cf595","filters":{"venue":"Cardiovascular Drugs and Therapy"},"cohort_total":85,"direct_labels_cover":0,"predictions_cover":85,"exported":85,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/3c17a53cf595","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cardiovascular+Drugs+and+Therapy"},"results":[{"id":"W1233590792","doi":"10.1007/s10557-012-6434-9","title":"Beneficial Effects of Grape Resveratrol on Serum Adiponectin and Inflammation: Clinical Trial in Patients with Stable Coronary Artery Disease","year":2013,"lang":"en","type":"letter","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Coronary artery disease; Cardiology; Clopidogrel; Resveratrol; Internal medicine; Heart failure; Myocardial infarction; Atorvastatin; Aspirin; Prasugrel; Pharmacology","score_opus":0.009645027061187968,"score_gpt":0.2247236426147435,"score_spread":0.21507861555355554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1233590792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71994954,0.060871985,0.0007320423,0.17738312,0.012527686,0.0008264835,0.0022232318,0.00026457422,0.02522138],"genre_scores_gemma":[0.88774574,0.015370916,0.0013021933,0.07424101,0.012290875,0.00050453894,0.0009743187,0.00003033537,0.0075398954],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997068,0.00013365896,0.000033976798,0.00003889705,0.000044449036,0.000042186406],"domain_scores_gemma":[0.9993113,0.00037239873,0.0000731671,0.000032178992,0.00007063736,0.00014033454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009789142,0.00060232024,0.0023171569,0.00017508089,0.00045092643,0.00081266236,0.00054713263,0.0035758775,0.0033076499],"category_scores_gemma":[0.002101419,0.00028465225,0.0010063852,0.00033421133,0.0005093735,0.00045909884,0.00025333915,0.0043961504,0.00083809486],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43723962,0.006400148,0.05193195,0.0036652954,0.0047280947,0.011560707,0.00036075842,0.0010279159,0.017233215,0.0015827281,0.14617936,0.3180902],"study_design_scores_gemma":[0.5511854,0.06656089,0.21710792,0.0014321024,0.0097359,0.006909122,0.0007362768,0.0042399513,0.0054599256,0.0050534243,0.13129573,0.00028331613],"about_ca_topic_score_codex":0.00079868734,"about_ca_topic_score_gemma":0.0033272775,"teacher_disagreement_score":0.0035758775,"about_ca_system_score_codex":0.0007142247,"about_ca_system_score_gemma":0.0005578862,"threshold_uncertainty_score":0.011065185},"labels":[],"label_agreement":null},{"id":"W1416265763","doi":"10.1023/a:1012766816853","title":"The Role of Measurement in the Health Care of the Elderly","year":2001,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.02110591682372141,"score_gpt":0.2999671033756773,"score_spread":0.27886118655195585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1416265763","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046542402,0.46121165,0.07317914,0.3410754,0.012108022,0.0002819893,0.0007505186,0.00083025923,0.06402067],"genre_scores_gemma":[0.65476054,0.21746026,0.081064716,0.030945474,0.011343246,0.0007169501,0.0002652875,0.00018204136,0.0032615752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9738173,0.019208523,0.0015535736,0.0009332347,0.0039808657,0.0005065154],"domain_scores_gemma":[0.86334944,0.1028464,0.009160734,0.005951358,0.013510196,0.00518185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042411227,0.0010236582,0.0018723159,0.0026221967,0.002051331,0.0050243028,0.002111774,0.0031301545,0.002256199],"category_scores_gemma":[0.10318871,0.0003991235,0.0006662983,0.0033427116,0.004815656,0.0058307108,0.0029288253,0.00572831,0.00051716325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003178802,0.00048845005,0.1144067,0.002512572,0.00022133261,0.00016518214,0.0035676518,0.0012904388,0.00094566995,0.027523749,0.0393062,0.80925417],"study_design_scores_gemma":[0.000219618,0.0024288467,0.3296684,0.01299763,0.0005399458,0.0030764022,0.011781702,0.011056039,0.0018040312,0.28286803,0.342925,0.0006344345],"about_ca_topic_score_codex":0.011732674,"about_ca_topic_score_gemma":0.011266169,"teacher_disagreement_score":0.042411227,"about_ca_system_score_codex":0.002929998,"about_ca_system_score_gemma":0.011870223,"threshold_uncertainty_score":0.22429466},"labels":[],"label_agreement":null},{"id":"W169488438","doi":"10.1023/a:1013723922582","title":"Apoptosis in Cardiovascular Remodeling—Effect of Medication","year":2001,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Apoptosis; Stimulus (psychology); Programmed cell death; Angiotensin II; Heart failure; Cell growth; Cell; Bioinformatics; Population; Cancer research; Neuroscience; Internal medicine; Receptor; Biology; Genetics","score_opus":0.03225228069997644,"score_gpt":0.30236414953210056,"score_spread":0.2701118688321241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W169488438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006178908,0.9995509,0.000034276756,0.000077577315,0.00007180253,0.0000018481145,0.0000061362766,0.0000019353486,0.00019365324],"genre_scores_gemma":[0.0004802572,0.9990115,0.00009309732,0.00010263368,0.00013481553,0.00000348294,0.000010480552,4.5296906e-7,0.00016319839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969745,0.00006074554,0.00006009357,0.00005777026,0.00010576746,0.00001818252],"domain_scores_gemma":[0.9993795,0.0003565863,0.000105879124,0.000016683347,0.00011386069,0.000027336833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084494305,0.0012798511,0.0034250258,0.0030708192,0.0003207444,0.0012178968,0.0011601687,0.0012894566,0.0024080342],"category_scores_gemma":[0.0011024016,0.00038435694,0.00066844653,0.0034447191,0.0006657356,0.0015013767,0.00064873946,0.001412103,0.00095861737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024914087,0.00009517309,0.00036106497,0.01948015,0.00021394982,0.00021971345,0.000046402158,0.00027691363,0.001016656,0.0011226228,0.014963265,0.96195483],"study_design_scores_gemma":[0.0002363122,0.00059461367,0.005248236,0.015564082,0.0011698683,0.0032000558,0.0002016099,0.0002907566,0.0011005832,0.0038336762,0.9684945,0.00006575509],"about_ca_topic_score_codex":0.0014629575,"about_ca_topic_score_gemma":0.0037361674,"teacher_disagreement_score":0.0034250258,"about_ca_system_score_codex":0.0006127736,"about_ca_system_score_gemma":0.0010136077,"threshold_uncertainty_score":0.008055627},"labels":[],"label_agreement":null},{"id":"W17048978","doi":"10.1023/a:1007868317306","title":"Platelet Cyclic GMP Responses to Nitroglycerin","year":2000,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Platelet; Cyclic guanosine monophosphate; Transdermal; Cyclic gmp; Pharmacology; Internal medicine; Platelet activation; Sublingual administration; Saline; Endocrinology; Anesthesia; Nitric oxide","score_opus":0.015372110080380925,"score_gpt":0.25180141536299383,"score_spread":0.2364293052826129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W17048978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98696333,0.0016921074,0.00044564958,0.00040401166,0.0002546855,0.00010292805,0.00043902796,0.000047464244,0.009650758],"genre_scores_gemma":[0.99378395,0.00082837394,0.0002626855,0.00026570592,0.00020879875,0.00009676248,0.00049325597,0.000012650408,0.004047774],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99964607,0.00013360777,0.000017490396,0.000030439307,0.000056398985,0.000116028314],"domain_scores_gemma":[0.99871194,0.0007595502,0.00008579648,0.00014445696,0.00006476233,0.00023344909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050465233,0.0006749211,0.0007357025,0.0004683966,0.00050907355,0.00054993166,0.0004373461,0.0010400662,0.004731182],"category_scores_gemma":[0.0020466957,0.0004854359,0.00048508254,0.0004997775,0.0011806464,0.0005035868,0.00035926845,0.0018497584,0.0007798286],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2773962,0.0045251716,0.0065822373,0.00055069884,0.00037242557,0.007082843,0.0021758918,0.0018242208,0.6564469,0.0040944493,0.0027859185,0.03616312],"study_design_scores_gemma":[0.0068581887,0.06842676,0.21417361,0.00012533921,0.00057604926,0.0042626876,0.0020466812,0.0063233976,0.6871195,0.0023704532,0.007596563,0.00012079083],"about_ca_topic_score_codex":0.0023836745,"about_ca_topic_score_gemma":0.00256548,"teacher_disagreement_score":0.004731182,"about_ca_system_score_codex":0.0005535418,"about_ca_system_score_gemma":0.000503025,"threshold_uncertainty_score":0.015827358},"labels":[],"label_agreement":null},{"id":"W1819973517","doi":"10.1023/a:1015709617405","title":"Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report","year":2002,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Ottawa; Hamilton General Hospital","funders":"","keywords":"Medicine; Endothelial dysfunction; Endothelium; ACE inhibitor; Nitric oxide; Angiotensin-converting enzyme; Angiotensin II; Inflammation; Coronary artery disease; Vasodilation; Pharmacology; Blood pressure; Pathological; Internal medicine","score_opus":0.05614567491605384,"score_gpt":0.3162287788765293,"score_spread":0.26008310396047546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1819973517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013863458,0.99792504,0.00028979586,0.00094482576,0.0002931325,0.00000813293,0.000023210714,0.0000046254736,0.00037264396],"genre_scores_gemma":[0.0014100501,0.99605703,0.00087705185,0.00070384634,0.00061629375,0.000015140899,0.000048231894,0.0000017696836,0.000270475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993685,0.00009391849,0.00020091185,0.000105043386,0.00019452888,0.00003714915],"domain_scores_gemma":[0.9979861,0.0011089857,0.0003415573,0.000041093997,0.00044938945,0.00007294294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023408316,0.0011071265,0.0032398875,0.0022156294,0.00023445638,0.0016953463,0.0016290466,0.0020512715,0.0014674992],"category_scores_gemma":[0.0027178715,0.00036248102,0.0010441571,0.0021333657,0.00057913375,0.0018993284,0.0007215944,0.0020656264,0.0010330082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004464829,0.00010354614,0.00065773854,0.027450489,0.0004076248,0.0014542345,0.00006545974,0.0004280935,0.0017253823,0.0019869816,0.033526994,0.931747],"study_design_scores_gemma":[0.00033877802,0.00033882103,0.0039097155,0.022373078,0.0025830665,0.0092971595,0.00020148381,0.00051493937,0.0023553248,0.0030300638,0.95496994,0.00008765318],"about_ca_topic_score_codex":0.0009010247,"about_ca_topic_score_gemma":0.001734795,"teacher_disagreement_score":0.0032398875,"about_ca_system_score_codex":0.0007732644,"about_ca_system_score_gemma":0.0024180505,"threshold_uncertainty_score":0.012379706},"labels":[],"label_agreement":null},{"id":"W1963966252","doi":"10.1007/s10557-008-6084-0","title":"Medium-chain Fatty Acids as Metabolic Therapy in Cardiac Disease","year":2008,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Disease; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.025475242959629264,"score_gpt":0.2814907708382918,"score_spread":0.25601552787866255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963966252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014457724,0.99869066,0.00012310913,0.00016008598,0.0001725612,0.0000050779486,0.000015046111,0.0000059495665,0.0006828756],"genre_scores_gemma":[0.0009937448,0.9977106,0.00023853687,0.00022947416,0.0002529013,0.000008627891,0.000025025318,0.0000014049697,0.0005396774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998313,0.000032557018,0.00004267504,0.000027969152,0.000051113446,0.000014375636],"domain_scores_gemma":[0.9995765,0.00022016752,0.00010424504,0.000010569613,0.000057533245,0.00003092317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000596154,0.0010812192,0.0021574353,0.0024305615,0.00019328928,0.0007935794,0.0007746273,0.0011265852,0.004289218],"category_scores_gemma":[0.0007718598,0.00030644637,0.0005300445,0.0022229934,0.000395964,0.0011596731,0.0006622164,0.0017368481,0.0017775773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000248059,0.00012328802,0.00013533141,0.017298557,0.00019689102,0.00017253908,0.000026132711,0.0002258745,0.0012877928,0.0010094866,0.015369106,0.9639069],"study_design_scores_gemma":[0.00029103726,0.00054357626,0.002223652,0.01038353,0.0013768305,0.0024042092,0.00008753094,0.0003028881,0.0011124061,0.0017122639,0.97952086,0.00004119838],"about_ca_topic_score_codex":0.0006991732,"about_ca_topic_score_gemma":0.0021718834,"teacher_disagreement_score":0.004289218,"about_ca_system_score_codex":0.00037407543,"about_ca_system_score_gemma":0.00072188256,"threshold_uncertainty_score":0.014348865},"labels":[],"label_agreement":null},{"id":"W1969661498","doi":"10.1007/s10557-008-6095-x","title":"Myocardial Metabolism—Therapeutic Aspects","year":2008,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Metabolism; Intensive care medicine; Internal medicine","score_opus":0.01880403063579309,"score_gpt":0.2275504786892867,"score_spread":0.20874644805349363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969661498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037230381,0.94847435,0.0012603905,0.019288002,0.0028986519,0.000031192227,0.000075066695,0.000032123928,0.024217146],"genre_scores_gemma":[0.070798405,0.8761083,0.002595413,0.014867952,0.015037265,0.00012070557,0.0002451105,0.000029619096,0.0201972],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997923,0.00006351618,0.000020673297,0.000032302272,0.000052500665,0.000038828402],"domain_scores_gemma":[0.9998565,0.00003625137,0.000028028386,0.000014432346,0.000033822165,0.00003098704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066491327,0.00058590947,0.00085531734,0.0006049581,0.00039458086,0.0013454766,0.0005247636,0.0014471236,0.006610819],"category_scores_gemma":[0.00050377403,0.0001336789,0.00044232135,0.00045698887,0.00042630723,0.0008002075,0.0005478598,0.0023277735,0.0024286185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009302522,0.000608787,0.00081648486,0.002761382,0.00014579332,0.0010823952,0.00009852328,0.00030850293,0.010329268,0.022223292,0.04321166,0.91748375],"study_design_scores_gemma":[0.000573282,0.0024618034,0.007582711,0.0032540911,0.00021132288,0.0064080893,0.0001984411,0.00057290384,0.0054497123,0.025898708,0.947347,0.000041906485],"about_ca_topic_score_codex":0.0003066746,"about_ca_topic_score_gemma":0.00060529,"teacher_disagreement_score":0.006610819,"about_ca_system_score_codex":0.00053820387,"about_ca_system_score_gemma":0.00047573706,"threshold_uncertainty_score":0.02211535},"labels":[],"label_agreement":null},{"id":"W1974190108","doi":"10.1007/s10557-013-6505-6","title":"Two Sides of the One Coin—the Cardiac and Vascular System","year":2013,"lang":"en","type":"letter","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Park","funders":"","keywords":"Medicine; Cardiology; Internal medicine","score_opus":0.01238794420278415,"score_gpt":0.20650816467173608,"score_spread":0.19412022046895192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974190108","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004965705,0.0035795171,0.00015651269,0.9865393,0.007927201,0.0000031845718,0.000007190203,0.000008779528,0.0012817178],"genre_scores_gemma":[0.008552366,0.004764385,0.00043802444,0.88741714,0.09696569,0.00001480575,0.000011500463,0.000014588028,0.0018214755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99522036,0.0022927925,0.00042754828,0.0006533975,0.0009585833,0.0004472264],"domain_scores_gemma":[0.98845226,0.0075135464,0.0007199235,0.00033780403,0.0012813369,0.0016950713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035583088,0.00083225075,0.002699381,0.00089295965,0.003917599,0.0044767475,0.00181579,0.04508371,0.0077597178],"category_scores_gemma":[0.02056707,0.00064096117,0.0010912166,0.0007173031,0.0065230182,0.010916524,0.0027632972,0.06297666,0.0028843526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034063437,0.00020691595,0.0032848932,0.00025407906,0.00012742994,0.01496968,0.00065334566,0.00022316715,0.00052865915,0.0297647,0.9005632,0.04908342],"study_design_scores_gemma":[0.000660845,0.00023016677,0.0029451542,0.0013716305,0.00012463107,0.02587411,0.0028585256,0.001347366,0.0004198492,0.13511124,0.8287839,0.0002725211],"about_ca_topic_score_codex":0.0024619058,"about_ca_topic_score_gemma":0.004396555,"teacher_disagreement_score":0.04508371,"about_ca_system_score_codex":0.0036635466,"about_ca_system_score_gemma":0.0028799702,"threshold_uncertainty_score":0.02658099},"labels":[],"label_agreement":null},{"id":"W1978518503","doi":"10.1007/s10557-013-6507-4","title":"Tmem time: Memory T-Cells in Cardiac Allograft Vasculopathy","year":2014,"lang":"en","type":"letter","venue":"Cardiovascular Drugs and Therapy","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cardiac allograft vasculopathy; Cardiology; Coronary arteries; Ischemia; Transplantation; Internal medicine; Coronary artery disease; Disease; Heart transplantation; Intravascular ultrasound; Thickening; Artery","score_opus":0.013434509974352367,"score_gpt":0.2416855428441584,"score_spread":0.22825103286980605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978518503","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066084606,0.020548042,0.0011254001,0.9148506,0.035958577,0.000084347914,0.0000792878,0.00015583678,0.020589462],"genre_scores_gemma":[0.08292212,0.022276668,0.0015778104,0.608539,0.25808728,0.00015131623,0.000103603554,0.000063099294,0.026279116],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911064,0.00034687133,0.00008462028,0.00011080512,0.00022286567,0.00012428936],"domain_scores_gemma":[0.99834776,0.0010908918,0.0001199215,0.00006281517,0.00021072484,0.0001677522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011560621,0.000614474,0.0008775665,0.0004153532,0.0011120178,0.0015159452,0.00094064855,0.0141898375,0.0052276882],"category_scores_gemma":[0.005921557,0.00020084823,0.0005224053,0.00037340206,0.0015140834,0.0018435542,0.0004659862,0.010928747,0.00415067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007213984,0.00028896634,0.004424792,0.00053126016,0.00005397385,0.054757044,0.0002302501,0.00046341686,0.0018039639,0.01308485,0.7710134,0.15262668],"study_design_scores_gemma":[0.00067225256,0.0007281056,0.0054933256,0.0015193791,0.00008467928,0.06924471,0.0003763513,0.002168496,0.0013180141,0.04421114,0.8741315,0.000052051415],"about_ca_topic_score_codex":0.0004455186,"about_ca_topic_score_gemma":0.0008209672,"teacher_disagreement_score":0.0141898375,"about_ca_system_score_codex":0.002119257,"about_ca_system_score_gemma":0.0007807829,"threshold_uncertainty_score":0.01748836},"labels":[],"label_agreement":null},{"id":"W1980577888","doi":"10.1007/s10557-014-6558-1","title":"Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation","year":2014,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National University of Singapore","keywords":"Medicine; Rivaroxaban; Dabigatran; Atrial fibrillation; Warfarin; Stroke (engine); Internal medicine; Cardiology","score_opus":0.036744853119170695,"score_gpt":0.2902914727892276,"score_spread":0.2535466196700569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980577888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830836,0.011667605,0.00020082765,0.0019549073,0.00027688142,0.00011366833,0.00056735607,0.0000096950625,0.0021253827],"genre_scores_gemma":[0.99775416,0.001265594,0.00018717881,0.0002186748,0.00010196417,0.00003296786,0.00028403744,0.0000020873022,0.00015328899],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997712,0.0012020345,0.00033892403,0.00019015506,0.00022872114,0.00032805218],"domain_scores_gemma":[0.99706095,0.0016653615,0.00058986834,0.00010284421,0.000145443,0.00043548452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017330601,0.0007218716,0.0022599623,0.00080650084,0.00042124107,0.0017834693,0.00067144126,0.001420424,0.003906888],"category_scores_gemma":[0.0104905665,0.00051234604,0.0060854307,0.0009410106,0.0004879532,0.0019596638,0.0009749199,0.0016898047,0.0001553933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5549835,0.0053125178,0.26551658,0.002817355,0.027088745,0.00094452547,0.00040562835,0.02007856,0.0014330298,0.0025198662,0.0027956956,0.11610396],"study_design_scores_gemma":[0.1222148,0.06453235,0.69526654,0.0013561564,0.054479163,0.0017769367,0.0025248947,0.047165766,0.0014294289,0.005876068,0.0030147342,0.00036314336],"about_ca_topic_score_codex":0.009329966,"about_ca_topic_score_gemma":0.011114307,"teacher_disagreement_score":0.009329966,"about_ca_system_score_codex":0.0027595889,"about_ca_system_score_gemma":0.0016808554,"threshold_uncertainty_score":0.020022333},"labels":[],"label_agreement":null},{"id":"W2000857749","doi":"10.1007/s10557-012-6373-5","title":"ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies","year":2012,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Medicine; Intensive care medicine; Pharmacology","score_opus":0.032372533228771955,"score_gpt":0.2947657922874573,"score_spread":0.2623932590586854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000857749","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43522072,0.21804824,0.09094065,0.13325743,0.013722921,0.009213774,0.0030718104,0.0015354506,0.09498904],"genre_scores_gemma":[0.7752874,0.08462821,0.07429077,0.030920783,0.013987669,0.005830644,0.0012210814,0.00044641938,0.013386969],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99695075,0.0015319287,0.00037536785,0.0003148771,0.0005843594,0.00024269847],"domain_scores_gemma":[0.98791635,0.007275981,0.0009455597,0.0016406929,0.0011592965,0.0010621292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020719431,0.0011001937,0.0025931085,0.0010229143,0.0010103066,0.0033827834,0.0020542538,0.0031781995,0.004301891],"category_scores_gemma":[0.015795529,0.0004922776,0.0021648812,0.00079142785,0.004509392,0.0027313202,0.0021944803,0.0091533,0.001009686],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10106881,0.010165413,0.010885276,0.003860183,0.0016436111,0.0009706318,0.00064552063,0.0020556683,0.035042915,0.1821193,0.019917328,0.6316254],"study_design_scores_gemma":[0.05995161,0.1871845,0.017606718,0.0046162405,0.006611375,0.0036672074,0.0010030197,0.010094123,0.18296076,0.13368507,0.3920751,0.00054429367],"about_ca_topic_score_codex":0.000611119,"about_ca_topic_score_gemma":0.0009381103,"teacher_disagreement_score":0.020719431,"about_ca_system_score_codex":0.0012757478,"about_ca_system_score_gemma":0.0043177637,"threshold_uncertainty_score":0.109576106},"labels":[],"label_agreement":null},{"id":"W2002782120","doi":"10.1007/s10557-006-0633-1","title":"Cardiac Metabolism and Mechanics are Altered by Genetic Loss of Lipoprotein Triglyceride Lipolysis","year":2006,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Lipoprotein lipase; Lipolysis; Fatty acid; Triglyceride; Internal medicine; Adipose tissue; Endocrinology; Lipid metabolism; Beta oxidation; Adipose triglyceride lipase; Medicine; Fatty acid metabolism; Chylomicron; Lipoprotein; Biochemistry; Metabolism; Very low-density lipoprotein; Chemistry; Cholesterol","score_opus":0.014154817447909878,"score_gpt":0.24861132994147692,"score_spread":0.23445651249356703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002782120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007719296,0.9966453,0.0006739494,0.00025411538,0.00020937437,0.0000047129906,0.00002235581,0.00002305363,0.0013951864],"genre_scores_gemma":[0.0038044786,0.9935027,0.00074556685,0.0002473718,0.0003282461,0.000010305339,0.000042693835,0.0000030501128,0.0013156511],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999008,0.000010868159,0.000020772046,0.000021532729,0.000037037098,0.000008991779],"domain_scores_gemma":[0.9998418,0.00006212149,0.00004814383,0.0000058589694,0.000027431974,0.00001459002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023879748,0.0009673024,0.0014776996,0.0012108646,0.00012738147,0.0005065642,0.00047280526,0.00070048275,0.0016922203],"category_scores_gemma":[0.00031490566,0.00017452087,0.0003094722,0.0009080704,0.00037470076,0.0006038038,0.00035990882,0.00082989637,0.0011817602],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019254068,0.00007154781,0.0005321195,0.0042349705,0.00011624747,0.00075891917,0.000022463826,0.00026558604,0.011336044,0.0014107233,0.008651368,0.97240746],"study_design_scores_gemma":[0.00014246782,0.0004484208,0.008093782,0.0030298687,0.0008785533,0.012822001,0.00012647652,0.00046562043,0.010334453,0.0043857596,0.9592051,0.00006757866],"about_ca_topic_score_codex":0.00035814664,"about_ca_topic_score_gemma":0.0006897374,"teacher_disagreement_score":0.0016922203,"about_ca_system_score_codex":0.00024076289,"about_ca_system_score_gemma":0.00041193527,"threshold_uncertainty_score":0.0056610107},"labels":[],"label_agreement":null},{"id":"W2003697485","doi":"10.1007/s10557-013-6502-9","title":"Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody","year":2013,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Medicine; Monoclonal antibody; Monoclonal; Antibody; Cardiac allograft vasculopathy; Immunology; Transplantation; Heart transplantation; Internal medicine","score_opus":0.008224928092591963,"score_gpt":0.24182356287318915,"score_spread":0.2335986347805972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003697485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944384,0.0052706427,0.0019467393,0.00016116563,0.000088198365,0.000057301862,0.00006427751,0.00008688349,0.002880805],"genre_scores_gemma":[0.9955515,0.0013664839,0.0006097479,0.000111152476,0.000098582,0.000053691932,0.00008991278,0.0000069235766,0.0021120058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996643,0.00010108268,0.000021304993,0.000032010015,0.00005276412,0.0001284488],"domain_scores_gemma":[0.9998641,0.000032366177,0.000047959857,0.000017872766,0.000013052571,0.000024615187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006852324,0.0005223408,0.00033001867,0.00044120286,0.0001434868,0.00047769994,0.00031573747,0.00041995925,0.0016512729],"category_scores_gemma":[0.00033826634,0.00014542774,0.00027037784,0.00015833307,0.0002240354,0.00038628854,0.00026770352,0.0007976472,0.00029466787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057677296,0.0025106135,0.009764571,0.0004390138,0.00013084344,0.00059525843,0.00019839451,0.000519392,0.8443331,0.0029398352,0.0012789569,0.13152228],"study_design_scores_gemma":[0.0012396851,0.01411844,0.03204608,0.00010322555,0.00041028252,0.0023057482,0.00020210196,0.0027554776,0.9279946,0.0013316347,0.017471043,0.000021717755],"about_ca_topic_score_codex":0.00012739739,"about_ca_topic_score_gemma":0.00015823255,"teacher_disagreement_score":0.0016512729,"about_ca_system_score_codex":0.00022723437,"about_ca_system_score_gemma":0.00019484341,"threshold_uncertainty_score":0.005524099},"labels":[],"label_agreement":null},{"id":"W2023433747","doi":"10.1007/s10557-007-6011-9","title":"Long-term Risk of Ischemic Stroke Associated with Rofecoxib","year":2007,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Rofecoxib; Medicine; Placebo; Stroke (engine); Relative risk; Internal medicine; Clinical trial; Confidence interval; Surgery; Anesthesia; Alternative medicine; Pathology","score_opus":0.006289215591809196,"score_gpt":0.21974930148679817,"score_spread":0.21346008589498897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023433747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927181,0.0036520206,0.00018199404,0.00022434954,0.000045330897,0.000009225661,0.00038605026,0.0000123167565,0.0027705505],"genre_scores_gemma":[0.9976464,0.00086025527,0.00007877383,0.000054877946,0.00015584788,0.0000054577918,0.00047085108,0.0000021352685,0.0007254204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996636,0.00009731278,0.00004116217,0.000043232063,0.00006263327,0.00009207162],"domain_scores_gemma":[0.99813855,0.00036909909,0.000644697,0.00017639094,0.00019975193,0.0004715454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049557374,0.00036055583,0.000691002,0.0005332007,0.00055485737,0.0006283646,0.00024003974,0.00084507064,0.0029107789],"category_scores_gemma":[0.001977806,0.00022947388,0.00076108973,0.0007076531,0.0002478295,0.000444656,0.00033345263,0.0009987872,0.00038563414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054360083,0.0001974793,0.9861842,0.000042921973,0.0005306643,0.0010947504,0.000034785506,0.000097836666,0.00079819415,0.00007981153,0.00024157534,0.0052617076],"study_design_scores_gemma":[0.000053186053,0.00051188515,0.9970048,0.0000107294345,0.0003056498,0.0012442459,0.000052026437,0.00024935944,0.00011401264,0.00010749012,0.00033718807,0.00000939542],"about_ca_topic_score_codex":0.0027446472,"about_ca_topic_score_gemma":0.0036619718,"teacher_disagreement_score":0.0029107789,"about_ca_system_score_codex":0.00028549263,"about_ca_system_score_gemma":0.00042859087,"threshold_uncertainty_score":0.009737551},"labels":[],"label_agreement":null},{"id":"W2029063449","doi":"10.1007/s10557-012-6399-8","title":"High Molecular Weight Calmodulin-Binding Protein: 20 Years Onwards—A Potential Therapeutic Calpain Inhibitor","year":2012,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Calpain Protease Function and Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Calpain; Calpastatin; Proteases; Proteolysis; Calmodulin; Cytosol; Intracellular; Cell biology; Apoptosis; Ischemia; Medicine; Biochemistry; Biology; Internal medicine; Enzyme","score_opus":0.012585025910676466,"score_gpt":0.235678190703153,"score_spread":0.2230931647924765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029063449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026606888,0.99775,0.00028756948,0.00038046332,0.00037358908,0.0000076260226,0.00002654673,0.000016055466,0.00089203165],"genre_scores_gemma":[0.0015770585,0.99540097,0.00051318796,0.0006160144,0.00046538003,0.000014213471,0.000080143654,0.000004387744,0.0013287492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998623,0.0000175592,0.000019611469,0.000028349506,0.000052343956,0.000019821611],"domain_scores_gemma":[0.9997788,0.0000818321,0.00003674926,0.000006961601,0.000060490907,0.00003520313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000495522,0.0009867596,0.0015921496,0.001322385,0.00022361777,0.0007580611,0.0009019781,0.000981877,0.002923465],"category_scores_gemma":[0.00059597025,0.00029492367,0.0003570542,0.0012352661,0.00053879485,0.001107302,0.00068372424,0.0024161292,0.0022812092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029927393,0.00014503278,0.0001448394,0.0083981445,0.00009260416,0.00026039957,0.000040219296,0.0002927997,0.006183505,0.0025483568,0.03863738,0.94295746],"study_design_scores_gemma":[0.00010586892,0.00026872687,0.00077707734,0.0012265864,0.0001621616,0.0012630646,0.000031612963,0.0001774412,0.001981191,0.0012987845,0.9926857,0.000021789152],"about_ca_topic_score_codex":0.0006679476,"about_ca_topic_score_gemma":0.0019525292,"teacher_disagreement_score":0.002923465,"about_ca_system_score_codex":0.0004949548,"about_ca_system_score_gemma":0.0006940346,"threshold_uncertainty_score":0.00977993},"labels":[],"label_agreement":null},{"id":"W2032265288","doi":"10.1007/s10557-005-4389-9","title":"Vasopeptidase Inhibition Peri- and Post-MI in Zucker Insulin Resistant Rats: Effect on MI Size, Arrhythmias, Remodeling, Function and Fetal Gene Expression","year":2005,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; St. Michael's Hospital; Toronto General Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Kinin; Insulin resistance; Cardiology; Myocardial infarction; Ventricular remodeling; Endocrinology; Insulin; Receptor; Bradykinin","score_opus":0.007183772763899312,"score_gpt":0.22036873492293982,"score_spread":0.2131849621590405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032265288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677,0.00080167176,0.001028523,0.00019913231,0.00008151638,0.000036238616,0.00044480653,0.00006567213,0.0005724374],"genre_scores_gemma":[0.9898078,0.001247736,0.0019890924,0.000114132774,0.00007524531,0.00016194966,0.0007775845,0.000058519126,0.0057678865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996853,0.000041058305,0.000032217504,0.000067265755,0.000039276496,0.00013491405],"domain_scores_gemma":[0.99927896,0.00012443628,0.00017655897,0.00008887786,0.000033195905,0.00029791158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003552789,0.0009378877,0.000959762,0.0007904521,0.0004112098,0.00046817053,0.0005227607,0.00063441263,0.0027616485],"category_scores_gemma":[0.00038233306,0.00052494975,0.00058767403,0.00038915637,0.0009687136,0.00090697786,0.00026746828,0.0023011838,0.00036536265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023944348,0.0009709985,0.0004401653,0.00006048906,0.000026219319,0.00019894277,0.00005637061,0.000111066125,0.9703552,0.00025183044,0.000102452585,0.003481918],"study_design_scores_gemma":[0.0007616934,0.007730574,0.0072615724,0.000010921508,0.00010190062,0.00022358172,0.00019758851,0.00083932397,0.9818464,0.00014096135,0.0008609915,0.000024374398],"about_ca_topic_score_codex":0.0014451046,"about_ca_topic_score_gemma":0.0023182947,"teacher_disagreement_score":0.0027616485,"about_ca_system_score_codex":0.00049147656,"about_ca_system_score_gemma":0.00063123653,"threshold_uncertainty_score":0.00923866},"labels":[],"label_agreement":null},{"id":"W2035188291","doi":"10.1007/s10557-012-6428-7","title":"Estrogen Metabolite 2-methoxyestradiol Prevents Hypertension in Deoxycorticosterone Acetate-salt Rats","year":2012,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Endocrinology; Blood pressure; Internal medicine; Estrogen; 2-Methoxyestradiol; Vasodilation","score_opus":0.039708251611056226,"score_gpt":0.29314879380074477,"score_spread":0.25344054218968853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035188291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960877,0.00118445,0.0009160343,0.00037809365,0.00021359582,0.000019611562,0.00038753817,0.00016546287,0.00064753165],"genre_scores_gemma":[0.9831202,0.0027808219,0.0013446066,0.00031915787,0.00021039255,0.000065941895,0.0009640215,0.000093887116,0.011100922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970573,0.000058607566,0.000031146643,0.00005258586,0.00005358381,0.00009831549],"domain_scores_gemma":[0.99902964,0.00014118108,0.00021653311,0.0001894592,0.00008765849,0.00033561714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003962551,0.000810855,0.001245991,0.001027197,0.00044424296,0.0004286068,0.00055067666,0.0007443172,0.0028367091],"category_scores_gemma":[0.00047342948,0.0006552225,0.0006571531,0.0004228687,0.0008856648,0.0008695787,0.00030959703,0.0018488378,0.0008335166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027089316,0.0028342716,0.0016144788,0.00011171277,0.00010515472,0.00024890987,0.000111074834,0.00017516053,0.958991,0.00025416433,0.0003079339,0.008156718],"study_design_scores_gemma":[0.0016299783,0.012511442,0.015873207,0.00002596309,0.0003538582,0.00020833788,0.00035747341,0.0010020477,0.9653179,0.00033906673,0.0023314052,0.000049325943],"about_ca_topic_score_codex":0.002073349,"about_ca_topic_score_gemma":0.0033699165,"teacher_disagreement_score":0.0028367091,"about_ca_system_score_codex":0.0003804285,"about_ca_system_score_gemma":0.0008847957,"threshold_uncertainty_score":0.009489715},"labels":[],"label_agreement":null},{"id":"W2037197248","doi":"10.1007/s10557-013-6487-4","title":"Docosahexaenoic Acid Supplementation Alters Key Properties of Cardiac Mitochondria and Modestly Attenuates Development of Left Ventricular Dysfunction in Pressure Overload-Induced Heart Failure","year":2013,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute","keywords":"Medicine; Heart failure; Pressure overload; Docosahexaenoic acid; Cardiology; Internal medicine; Mitochondrion; Fatty acid; Polyunsaturated fatty acid; Biochemistry; Cardiac hypertrophy","score_opus":0.01643858609786192,"score_gpt":0.2392233210318282,"score_spread":0.22278473493396628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037197248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961152,0.0019310405,0.00080016546,0.00028847,0.00015342195,0.000023993416,0.00021839702,0.000048868304,0.0004203086],"genre_scores_gemma":[0.9953681,0.0015745013,0.00081718026,0.00016451617,0.000055821343,0.00005554923,0.0003088505,0.000027053846,0.0016284244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980766,0.000037418125,0.000023338303,0.00003423919,0.000019278068,0.000078044024],"domain_scores_gemma":[0.99973756,0.00002541098,0.000065795,0.000033649794,0.000026555965,0.0001109834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019948265,0.0004912761,0.000923801,0.00032536357,0.0003069557,0.00056264264,0.00036939007,0.0005473794,0.0015685024],"category_scores_gemma":[0.00037153804,0.00029308908,0.0003296687,0.00021635626,0.00056280405,0.0006066163,0.00040678165,0.0010899294,0.00023466996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02265821,0.0005836969,0.0006492322,0.00011571872,0.000065617074,0.00010508362,0.00005074016,0.00005122031,0.9686614,0.000094447496,0.00013842045,0.006826279],"study_design_scores_gemma":[0.0016441395,0.013292509,0.030801956,0.00006960028,0.0004068363,0.00034097687,0.0004307321,0.0008396142,0.9491828,0.00033125494,0.0026189135,0.0000406956],"about_ca_topic_score_codex":0.0011890568,"about_ca_topic_score_gemma":0.0021382002,"teacher_disagreement_score":0.0015685024,"about_ca_system_score_codex":0.00035967046,"about_ca_system_score_gemma":0.0004385522,"threshold_uncertainty_score":0.005247116},"labels":[],"label_agreement":null},{"id":"W2046294034","doi":"10.1007/s10557-011-6311-y","title":"Mesenchymal Stem Cells for Cardiovascular Regeneration","year":2011,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Mesenchymal stem cell; Mesenchyme; Regeneration (biology); Medicine; Paracrine signalling; Stem cell; Cell biology; Regenerative medicine; Pathology; Bioinformatics; Biology; Internal medicine","score_opus":0.05849050248922302,"score_gpt":0.2799654986386663,"score_spread":0.2214749961494433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046294034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022800744,0.9953616,0.00063998305,0.00035944022,0.00068208796,0.000012227371,0.00003141407,0.000018475024,0.0026667896],"genre_scores_gemma":[0.0009489052,0.9946207,0.00055898423,0.00033411625,0.0004244329,0.00001408537,0.00005139622,0.0000038801577,0.0030434865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984753,0.000022051292,0.000025620817,0.000020568143,0.00006598253,0.000018213677],"domain_scores_gemma":[0.99980944,0.000081164006,0.00003346611,0.000007682691,0.000042878,0.00002534963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006492661,0.0013282854,0.0014799619,0.0025422703,0.0002713592,0.00089926645,0.0008171966,0.0010616366,0.0052237124],"category_scores_gemma":[0.000522359,0.00032362586,0.00041469705,0.0019488874,0.0005386819,0.0015147711,0.0010397345,0.001819343,0.0032266178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007905163,0.000082651655,0.00005353325,0.0071871625,0.000052532578,0.0001803571,0.00002714196,0.00028945706,0.00399843,0.0025952298,0.030028237,0.95542634],"study_design_scores_gemma":[0.000030321795,0.00008403064,0.00030028832,0.0015315046,0.00011102872,0.0008882568,0.000024340698,0.00010486115,0.00150171,0.0011517266,0.9942572,0.000014653436],"about_ca_topic_score_codex":0.00060360896,"about_ca_topic_score_gemma":0.002094222,"teacher_disagreement_score":0.0052237124,"about_ca_system_score_codex":0.00045605414,"about_ca_system_score_gemma":0.0009344305,"threshold_uncertainty_score":0.017475069},"labels":[],"label_agreement":null},{"id":"W2049045209","doi":"10.1007/s10557-013-6461-1","title":"What is the Role of Erythropoietin in Acute Myocardial Infarct? Bridging the Gap Between Experimental Models and Clinical Trials","year":2013,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; Fédération Française de Cardiologie; Amgen","keywords":"Erythropoietin; Medicine; Haematopoiesis; Clinical trial; Animal studies; Erythropoiesis; Myocardial infarction; Progenitor cell; Pharmacology; Bioinformatics; Internal medicine; Anemia; Stem cell","score_opus":0.11685455939293415,"score_gpt":0.4044784891357606,"score_spread":0.28762392974282647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049045209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044631415,0.9995092,0.000036198122,0.00020776856,0.00006386884,0.000005034489,0.0000110314795,0.0000010323752,0.00012130029],"genre_scores_gemma":[0.0004583966,0.9990839,0.000098021475,0.0002013556,0.000083797924,0.000007955516,0.00001101348,5.718654e-7,0.000055083157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994947,0.00015836085,0.000116860654,0.000063785075,0.00013884416,0.000027520513],"domain_scores_gemma":[0.99756,0.0018776308,0.00024787066,0.0000366726,0.00022533287,0.000052448024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027187904,0.00077570695,0.004526225,0.0016104548,0.00024094064,0.0016869417,0.0015312372,0.0018432908,0.0033202465],"category_scores_gemma":[0.004088664,0.0004207138,0.0015366091,0.001933211,0.00069210987,0.0017689856,0.000626167,0.0023814836,0.0007107127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005100331,0.00010444457,0.00022906007,0.12822051,0.001170007,0.00011705292,0.00006320816,0.000322282,0.00089186896,0.0039492347,0.015507594,0.8489147],"study_design_scores_gemma":[0.0008949473,0.00056919985,0.0026183454,0.11927288,0.0062671215,0.0011565821,0.0002472332,0.0004171991,0.00091112795,0.0075124423,0.8600496,0.00008343806],"about_ca_topic_score_codex":0.0016957701,"about_ca_topic_score_gemma":0.0033710296,"teacher_disagreement_score":0.004526225,"about_ca_system_score_codex":0.0006068789,"about_ca_system_score_gemma":0.0023143145,"threshold_uncertainty_score":0.014378488},"labels":[],"label_agreement":null},{"id":"W2051336160","doi":"10.1007/s10557-009-6190-7","title":"How Can We Improve the Management of Vascular Risk in Type 2 Diabetes: Insights from FIELD","year":2009,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Fenofibrate; Medicine; Fibrate; Dyslipidemia; Type 2 diabetes; Internal medicine; Diabetes mellitus; Metabolic syndrome; Diabetic retinopathy; Relative risk; Type 2 Diabetes Mellitus; Endocrinology; Statin","score_opus":0.015093042608351374,"score_gpt":0.24898470169554268,"score_spread":0.2338916590871913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051336160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006509821,0.99646497,0.0001692987,0.0024499688,0.00044799517,0.000003062132,0.000008573919,0.000006385185,0.00038459976],"genre_scores_gemma":[0.00041614857,0.9972995,0.0003298722,0.0011722085,0.00061997527,0.0000046861264,0.000010157688,0.0000012226357,0.00014630955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993754,0.00016116559,0.00009387482,0.00008274175,0.00023380252,0.000053035837],"domain_scores_gemma":[0.9979248,0.0012544605,0.00019855791,0.000055066972,0.00044123142,0.00012582952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026671968,0.0013269767,0.0041311127,0.0023429005,0.0004367393,0.0019681735,0.0013888672,0.0030752223,0.0027873393],"category_scores_gemma":[0.0031428493,0.0003972309,0.0010658432,0.0021700365,0.0011197291,0.0034813029,0.0010626403,0.0058397534,0.0018393095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014660104,0.00018565507,0.00037512043,0.012565771,0.0003262085,0.0001966999,0.00007143156,0.00035159575,0.0005894602,0.005671766,0.04537093,0.9341487],"study_design_scores_gemma":[0.00022294772,0.00024258629,0.0026552656,0.012416688,0.00058270345,0.0014026817,0.00021147457,0.00038299852,0.0003119769,0.012765382,0.96874255,0.000062716696],"about_ca_topic_score_codex":0.0023196994,"about_ca_topic_score_gemma":0.0048424834,"teacher_disagreement_score":0.0041311127,"about_ca_system_score_codex":0.0011017879,"about_ca_system_score_gemma":0.0022718853,"threshold_uncertainty_score":0.014105678},"labels":[],"label_agreement":null},{"id":"W2061060326","doi":"10.1023/b:card.0000015859.37581.f1","title":"Comparison of Cholesterol-Lowering Efficacy and Anti-Atherogenic Properties of Hydrogenated versus Non-Hydrogenated (Phytrol™) Tall Oil-Derived Phytosterols in Apo E-Deficient Mice","year":2003,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Campesterol; Cholesterol; Internal medicine; Medicine; Endocrinology; Phytosterol; Apolipoprotein B; Food science; Sterol; Chemistry","score_opus":0.028632772137141174,"score_gpt":0.267102868896873,"score_spread":0.23847009675973185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061060326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892825,0.00023356736,0.0003184824,0.000055618446,0.000020255551,0.000010841291,0.0002179605,0.0000240486,0.0001910336],"genre_scores_gemma":[0.9962747,0.0005205489,0.0008262561,0.00006324076,0.000030204894,0.0000361758,0.00047315093,0.000026662336,0.0017490558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998068,0.000028611603,0.000021565105,0.000031652493,0.000038557006,0.000072766],"domain_scores_gemma":[0.99939466,0.000119188604,0.00013389801,0.0000631038,0.000054502263,0.00023469326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003055595,0.00044866145,0.00057897763,0.0006193798,0.00020467662,0.00034749604,0.00037366024,0.00056049356,0.0013013063],"category_scores_gemma":[0.00025371238,0.0003006949,0.00041716284,0.00029630665,0.00061348034,0.00045467113,0.00019582402,0.0009441152,0.00022686073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022824092,0.00063723937,0.00051020394,0.00005088909,0.000052288666,0.00006853514,0.00003172315,0.00012384183,0.9729149,0.00009722005,0.000046619913,0.0026423368],"study_design_scores_gemma":[0.00079701527,0.007974372,0.003982586,0.0000067187484,0.00015256448,0.0000859953,0.000055093915,0.00050935714,0.98575324,0.00008176678,0.000585155,0.000016220414],"about_ca_topic_score_codex":0.00094444805,"about_ca_topic_score_gemma":0.00082412787,"teacher_disagreement_score":0.0013013063,"about_ca_system_score_codex":0.0002282678,"about_ca_system_score_gemma":0.00023251276,"threshold_uncertainty_score":0.0043533444},"labels":[],"label_agreement":null},{"id":"W2063449767","doi":"10.1007/s10557-008-6088-9","title":"What are the Biochemical Mechanisms Responsible for Enhanced Fatty Acid Utilization by Perfused Hearts from Type 2 Diabetic db/db Mice?","year":2008,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Type 2 diabetes; Internal medicine; Diabetes mellitus; Endocrinology; Cardiology","score_opus":0.042172026691269425,"score_gpt":0.2884868176481376,"score_spread":0.24631479095686817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063449767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048346331,0.99780685,0.00045251718,0.00048230716,0.00019335038,0.0000047847966,0.000039487153,0.000010571235,0.0005266477],"genre_scores_gemma":[0.00087565155,0.9981001,0.00035927244,0.00018803806,0.00013235467,0.000006662091,0.000032503278,0.000001492619,0.0003039306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988127,0.000013167848,0.000023743096,0.000025860736,0.000039959043,0.000016006015],"domain_scores_gemma":[0.9997291,0.00008177373,0.00007263506,0.000012106859,0.00007837584,0.000026044889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006683137,0.00096064294,0.0024139085,0.00091283984,0.00019681349,0.0011135319,0.0010926323,0.0011602262,0.0016406868],"category_scores_gemma":[0.00042429508,0.00035730313,0.0005440888,0.00089735346,0.0005700174,0.0014950224,0.0004445223,0.0017069725,0.001975321],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038783497,0.00013573618,0.0006046851,0.016301265,0.00021473419,0.00032120114,0.00005149219,0.0003027204,0.028671265,0.0025076831,0.010576284,0.939925],"study_design_scores_gemma":[0.00026074328,0.0007629165,0.0090313675,0.0070808567,0.0011945927,0.004558444,0.00036654598,0.00050183816,0.024980735,0.008433915,0.9426654,0.00016260137],"about_ca_topic_score_codex":0.0007897474,"about_ca_topic_score_gemma":0.0014582139,"teacher_disagreement_score":0.0024139085,"about_ca_system_score_codex":0.0004883152,"about_ca_system_score_gemma":0.00086553383,"threshold_uncertainty_score":0.005488634},"labels":[],"label_agreement":null},{"id":"W2082119340","doi":"10.1007/s10557-006-0634-0","title":"Malonyl-CoA Decarboxylase Inhibition as a Novel Approach to Treat Ischemic Heart Disease","year":2006,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta","funders":"","keywords":"Medicine; Disease; Internal medicine; Cardiology; Pharmacology","score_opus":0.02891684998415646,"score_gpt":0.2912550600121601,"score_spread":0.26233821002800367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082119340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005941215,0.99515116,0.0006043458,0.0004896784,0.00043427295,0.000014899197,0.000036710175,0.00002733611,0.0026474393],"genre_scores_gemma":[0.0025829857,0.9935916,0.00070250704,0.00041052306,0.00034043542,0.000017185534,0.00007678597,0.0000035330943,0.0022743696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990034,0.000017358898,0.000013995836,0.000018502007,0.000038300986,0.000011535982],"domain_scores_gemma":[0.9998776,0.000052428684,0.000020641883,0.000005240047,0.000028466378,0.000015623851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051482016,0.0010527205,0.002065091,0.0013648071,0.00023455209,0.00069453154,0.00080139603,0.0010601045,0.0038502212],"category_scores_gemma":[0.000350653,0.00024495387,0.00054233277,0.0011614254,0.00035307556,0.0007863115,0.0003548233,0.0017163679,0.0025833074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003814388,0.00021725622,0.00016483184,0.006868387,0.0002370823,0.0004270276,0.00003231431,0.00037298814,0.0056819418,0.0018795955,0.027174274,0.9565628],"study_design_scores_gemma":[0.00026674016,0.00053779257,0.0014935664,0.0013007484,0.00056893437,0.0020617004,0.000057753423,0.0002707901,0.002785448,0.0015689685,0.9890541,0.0000334146],"about_ca_topic_score_codex":0.000790807,"about_ca_topic_score_gemma":0.002635588,"teacher_disagreement_score":0.0038502212,"about_ca_system_score_codex":0.0004245548,"about_ca_system_score_gemma":0.0006518246,"threshold_uncertainty_score":0.012880266},"labels":[],"label_agreement":null},{"id":"W2085719256","doi":"10.1007/s10557-012-6397-x","title":"The Use of ω-3 Poly-Unsaturated Fatty Acids in Heart Failure: A Preferential Role in Patients with Diabetes","year":2012,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Health Canada; Alberta Innovates - Health Solutions; Heart Failure Society of America; Heart and Stroke Foundation of Canada","keywords":"Medicine; Polyunsaturated fatty acid; Diabetes mellitus; Insulin resistance; Coronary artery disease; Heart failure; Internal medicine; Atrial fibrillation; Clinical trial; Cardiology; Randomized controlled trial; Bioinformatics; Endocrinology; Fatty acid; Biochemistry","score_opus":0.032917882781472264,"score_gpt":0.2701889288897927,"score_spread":0.23727104610832042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085719256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024977155,0.9992536,0.00004100114,0.00011805373,0.000069234935,0.0000020788862,0.000007835599,0.0000012121296,0.00025734183],"genre_scores_gemma":[0.0014707666,0.99801195,0.000121841964,0.00016427228,0.00010077941,0.0000043256873,0.0000102940585,4.817613e-7,0.000115255825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997352,0.00006318474,0.00006642114,0.000046707,0.00006732263,0.000021186937],"domain_scores_gemma":[0.99921715,0.00043868946,0.0001883922,0.0000121394605,0.000112232534,0.000031333842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074648374,0.00065091916,0.0015101337,0.0018814541,0.00018496331,0.00059417036,0.00064218254,0.0009046049,0.0023658888],"category_scores_gemma":[0.0011856174,0.0002057477,0.00075715437,0.0016699424,0.00042042191,0.00064136076,0.00059690455,0.0011977084,0.00051304046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030740313,0.00009016148,0.0008126476,0.032715663,0.00038438695,0.00016706558,0.000064434214,0.000085016756,0.0011966833,0.00082264986,0.005012938,0.958341],"study_design_scores_gemma":[0.00045390084,0.0011437988,0.020195818,0.06065731,0.004399243,0.005105075,0.00054585416,0.00026592633,0.002216035,0.0023946362,0.90251803,0.00010437648],"about_ca_topic_score_codex":0.0015568606,"about_ca_topic_score_gemma":0.004113438,"teacher_disagreement_score":0.0023658888,"about_ca_system_score_codex":0.00034296373,"about_ca_system_score_gemma":0.0009349412,"threshold_uncertainty_score":0.007914662},"labels":[],"label_agreement":null},{"id":"W2089321175","doi":"10.1007/s10557-006-0582-8","title":"Regulation of Sarcolemmal Transport of Substrates in the Healthy and Diseased Heart","year":2006,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"GLUT4; Sarcolemma; CD36; Glucose uptake; Fatty acid; Internal medicine; Glucose transporter; Medicine; Myocyte; Biochemistry; Cardiac muscle; Endocrinology; Beta oxidation; Fatty acid metabolism; Metabolism; Biology; Insulin","score_opus":0.027703368206732082,"score_gpt":0.28558793695323675,"score_spread":0.25788456874650467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089321175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002516667,0.99874496,0.0002501723,0.00015690837,0.00009876693,0.000004137412,0.000014935586,0.000008164942,0.00047024435],"genre_scores_gemma":[0.0009236183,0.99823123,0.0003112511,0.000088137785,0.00008745155,0.0000053681083,0.000026266684,9.8702e-7,0.00032570527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998167,0.000027774866,0.000030392837,0.000036187306,0.00007060315,0.000018423802],"domain_scores_gemma":[0.9998072,0.00007447116,0.00004807321,0.000006700666,0.00004534003,0.000018332905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005540319,0.001031798,0.0025395174,0.0013843285,0.00024476758,0.0010183351,0.0011535666,0.0012626082,0.001671771],"category_scores_gemma":[0.0004166857,0.00031279944,0.00042779333,0.0015571624,0.0005669457,0.001207394,0.0006777369,0.0013927321,0.0017194656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001886714,0.00010662233,0.0002856351,0.013032681,0.00017266716,0.00038899088,0.000060817423,0.0005212657,0.00791726,0.0024839693,0.013429724,0.96141165],"study_design_scores_gemma":[0.00008455993,0.0002651825,0.0031953591,0.0029597115,0.0003980982,0.0032553491,0.00012324605,0.00035115765,0.0035575454,0.0032404673,0.98251915,0.00005010077],"about_ca_topic_score_codex":0.0007673238,"about_ca_topic_score_gemma":0.0014537708,"teacher_disagreement_score":0.0025395174,"about_ca_system_score_codex":0.0005077631,"about_ca_system_score_gemma":0.00077372324,"threshold_uncertainty_score":0.0055925846},"labels":[],"label_agreement":null},{"id":"W2156054021","doi":"10.1007/s10557-013-6489-2","title":"Remote Cardioprotection by Transfer of Coronary Effluent from Ischemic Preconditioned Rabbit Heart Preserves Mitochondrial Integrity and Function via Adenosine Receptor Activation","year":2013,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cardioprotection; Medicine; Adenosine; Adenosine receptor; Cardiology; Pharmacology; Internal medicine; Ischemia; Receptor; Agonist","score_opus":0.007442347291657633,"score_gpt":0.2044027494905084,"score_spread":0.19696040219885078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156054021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900997,0.0032960149,0.0040759197,0.00030107264,0.00013156589,0.00007250247,0.00011540362,0.00010088229,0.0018069535],"genre_scores_gemma":[0.99479973,0.0013013314,0.0020440752,0.00012195026,0.000063930005,0.0000372626,0.0001698157,0.00002584213,0.0014359711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998313,0.000023402241,0.000016729837,0.00004032531,0.000023156259,0.00006515749],"domain_scores_gemma":[0.9998229,0.00004029706,0.00004268046,0.000049090908,0.000016040029,0.000028936525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052279804,0.0005243514,0.00074055645,0.00021482568,0.00033460892,0.0005351734,0.00042800195,0.0005198534,0.0024218352],"category_scores_gemma":[0.00034951855,0.0002571822,0.00054296816,0.0001725245,0.000695198,0.0006355064,0.00030202372,0.0013300318,0.00035019696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022168201,0.000073241485,0.00014644365,0.00008361186,0.00002494227,0.00016147118,0.000079137586,0.000038816106,0.9949195,0.00032342112,0.00005237569,0.0018802482],"study_design_scores_gemma":[0.00025376122,0.00159417,0.0023847201,0.000016743163,0.00008348357,0.0002819363,0.000060033268,0.0006838648,0.9935568,0.00016343092,0.0009132247,0.000007806785],"about_ca_topic_score_codex":0.00088136137,"about_ca_topic_score_gemma":0.0011811496,"teacher_disagreement_score":0.0024218352,"about_ca_system_score_codex":0.0002698975,"about_ca_system_score_gemma":0.00047077143,"threshold_uncertainty_score":0.008101821},"labels":[],"label_agreement":null},{"id":"W2167714048","doi":"10.1023/a:1024295422944","title":"Drugs to Promote Sinus Rhythm Reversion and Maintenance in Atrial Fibrillation—Why Amiodarone is Better","year":2003,"lang":"en","type":"letter","venue":"Cardiovascular Drugs and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Mitacs","keywords":"Medicine; Amiodarone; Reversion; Sinus rhythm; Atrial fibrillation; Cardiology; Normal Sinus Rhythm; Rhythm; Internal medicine","score_opus":0.021601335840271543,"score_gpt":0.2571075374291344,"score_spread":0.23550620158886285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167714048","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028811183,0.018775735,0.00021131708,0.9578261,0.01324984,0.0000143004945,0.00008276748,0.0000467416,0.006912205],"genre_scores_gemma":[0.029589105,0.014263993,0.0006439186,0.83318263,0.11769672,0.00006756551,0.000085004096,0.000035073826,0.004435991],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985232,0.00040290953,0.00033870788,0.00017930065,0.0003629466,0.00019307408],"domain_scores_gemma":[0.99252594,0.0044480157,0.0006845515,0.00019229992,0.0010786641,0.0010703899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00203488,0.00048610548,0.0021242162,0.00063109363,0.0013277776,0.002152534,0.0007657387,0.018843817,0.0064233714],"category_scores_gemma":[0.01919209,0.0003123221,0.0013565524,0.00072815066,0.0014754069,0.0027062744,0.0005549415,0.019719543,0.0027872836],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020803974,0.00037715113,0.0063538556,0.00053929177,0.00035132564,0.0082452865,0.00015395721,0.00032789793,0.00077348127,0.008427082,0.82949924,0.14287098],"study_design_scores_gemma":[0.008498333,0.0015645883,0.020194314,0.0018762895,0.0010749586,0.019591324,0.00059372414,0.0017427955,0.0012594806,0.05148763,0.89186174,0.00025486588],"about_ca_topic_score_codex":0.002412889,"about_ca_topic_score_gemma":0.0061973557,"teacher_disagreement_score":0.018843817,"about_ca_system_score_codex":0.0022894386,"about_ca_system_score_gemma":0.0016957412,"threshold_uncertainty_score":0.021488369},"labels":[],"label_agreement":null},{"id":"W2170490363","doi":"10.1007/s10557-012-6422-0","title":"Berberine Attenuates Ischemia-Reperfusion Injury Via Regulation of Adenosine-5′-monophosphate Kinase Activity in Both Non-ischemic and Ischemic Areas of the Rat Heart","year":2012,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Berberine and alkaloids research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Berberine; Ischemia; AMPK; Internal medicine; Hemodynamics; Reperfusion injury; Anesthesia; Cardiology; Adenosine; Ventricular pressure; Protein kinase A; Pharmacology; Endocrinology; Phosphorylation; Biochemistry; Biology","score_opus":0.009706069781805706,"score_gpt":0.25122454419876916,"score_spread":0.24151847441696345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170490363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896129,0.0065082796,0.0012293498,0.00026608852,0.000087248605,0.000029037263,0.0001372765,0.00015856704,0.0019712665],"genre_scores_gemma":[0.99012077,0.0043617333,0.0010611919,0.00009498913,0.00007549095,0.00003619347,0.00023196593,0.000027725895,0.0039898986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992585,0.000013064687,0.0000052070122,0.000014740945,0.000010038311,0.000031077332],"domain_scores_gemma":[0.9998652,0.000019666439,0.00004918779,0.000016779666,0.000011831612,0.000037342168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017191708,0.0006392,0.0006951364,0.00037537093,0.00023599109,0.00029554855,0.00033429294,0.00042640007,0.0017977074],"category_scores_gemma":[0.00015544072,0.00025886338,0.00026896424,0.00016214781,0.00045391358,0.00055779476,0.00015991101,0.0010466959,0.000326955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036244548,0.00035238874,0.00018805405,0.00019654479,0.000025157346,0.00010890358,0.00004968909,0.00012265524,0.98868537,0.00023440496,0.00012795562,0.006284477],"study_design_scores_gemma":[0.00036217112,0.0039380663,0.009364527,0.000022363245,0.00009891765,0.00018489275,0.000055343335,0.0005846777,0.9836669,0.0001495084,0.0015579683,0.000014494521],"about_ca_topic_score_codex":0.0006917366,"about_ca_topic_score_gemma":0.0015768297,"teacher_disagreement_score":0.0017977074,"about_ca_system_score_codex":0.00029422436,"about_ca_system_score_gemma":0.00030035136,"threshold_uncertainty_score":0.00601393},"labels":[],"label_agreement":null},{"id":"W2173549682","doi":"10.1007/s10557-015-6628-z","title":"The Impact of Peripheral Nerve Stimulation on Coronary Blood Flow and Endothelial Function","year":2015,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Western University","keywords":"Medicine; Reactive hyperemia; Cardiology; Internal medicine; Blood flow; Peripheral; Stimulation; Coronary artery disease; Artery; Anesthesia","score_opus":0.018274712253699435,"score_gpt":0.273485948276598,"score_spread":0.2552112360228986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173549682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98983675,0.0049546584,0.00027891158,0.00026985927,0.00009325669,0.000022359267,0.00010114484,0.000008035507,0.004435112],"genre_scores_gemma":[0.9953157,0.0028010074,0.00023097284,0.00015233344,0.00017935678,0.000019641586,0.000059341306,0.000003977702,0.001237634],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998273,0.00007718288,0.000008430737,0.000019349547,0.000032162585,0.00003549554],"domain_scores_gemma":[0.9994512,0.00035446443,0.000056625,0.00003252928,0.00003167777,0.000073456824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041420438,0.00029979262,0.00030443736,0.00014917008,0.00016798558,0.00053920946,0.00017552418,0.00046749468,0.003849702],"category_scores_gemma":[0.0010616321,0.00012273273,0.00029625182,0.00017350476,0.0003961273,0.0003407953,0.0001758143,0.0006154983,0.00019376444],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20268011,0.0057731634,0.06102616,0.0013737065,0.0011682854,0.0014782341,0.0004356973,0.0025972074,0.2901619,0.0026023833,0.0011574798,0.42954567],"study_design_scores_gemma":[0.00293924,0.06265934,0.8997696,0.00018789503,0.0011170672,0.0016115963,0.00051416067,0.0024171812,0.023924323,0.0018226572,0.0029988098,0.00003808977],"about_ca_topic_score_codex":0.000932174,"about_ca_topic_score_gemma":0.0010260228,"teacher_disagreement_score":0.003849702,"about_ca_system_score_codex":0.00023868073,"about_ca_system_score_gemma":0.00044752678,"threshold_uncertainty_score":0.012878597},"labels":[],"label_agreement":null},{"id":"W2234429261","doi":"10.1007/s10557-015-6637-y","title":"Pharmacogenomics to Revive Drug Development in Cardiovascular Disease","year":2016,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Medicine; Drug development; Drug; Clinical trial; Disease; Intensive care medicine; Pharmacogenetics; Bioinformatics; Pharmacology; Internal medicine; Genetics","score_opus":0.032088515893481134,"score_gpt":0.29952753485543415,"score_spread":0.267439018961953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234429261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014501976,0.9971334,0.00041538026,0.00076634437,0.00025829254,0.000012326821,0.00002529982,0.000015024626,0.0012289013],"genre_scores_gemma":[0.0009803486,0.9970546,0.00040980714,0.00062491075,0.0003306071,0.000009855957,0.000028319575,0.0000019852916,0.00055965513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996731,0.00008929761,0.000060290433,0.00004119936,0.000105858024,0.000030242069],"domain_scores_gemma":[0.9991617,0.0004794059,0.0001570652,0.000025938914,0.00013006642,0.00004581253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013875616,0.0013020433,0.0023440456,0.0030534386,0.000228712,0.0013092234,0.0008454303,0.0014989168,0.005947809],"category_scores_gemma":[0.0017391251,0.00037645767,0.0010677385,0.0021664156,0.00062505057,0.0017568636,0.0011882925,0.0025935338,0.0020570876],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010963846,0.00015562288,0.00021163924,0.01967547,0.00036129198,0.0001995105,0.00003471002,0.0003706313,0.0012715084,0.0040108846,0.019550577,0.9540485],"study_design_scores_gemma":[0.00017506698,0.0003142011,0.0014114619,0.012348822,0.0012775359,0.001227182,0.000060240545,0.0003861273,0.0009921602,0.0069899624,0.97477484,0.000042411364],"about_ca_topic_score_codex":0.0005999763,"about_ca_topic_score_gemma":0.0017937638,"teacher_disagreement_score":0.005947809,"about_ca_system_score_codex":0.0006037353,"about_ca_system_score_gemma":0.0016362547,"threshold_uncertainty_score":0.019897342},"labels":[],"label_agreement":null},{"id":"W2293789009","doi":"10.1023/a:1011158717901","title":"Effects of Mibefradil, a T- and L-Type Calcium Channel Blocker, on Cardiac Remodeling in the UM-X7.1 Cardiomyopathic Hamster","year":2001,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Neurological Disorders and Treatments","field":"Neuroscience","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Mibefradil; Medicine; Internal medicine; Ventricle; Endocrinology; Cardiology; Cardiomyopathy; L-type calcium channel; Heart failure; Calcium; Voltage-dependent calcium channel","score_opus":0.027264816363177114,"score_gpt":0.24446856546970064,"score_spread":0.2172037491065235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293789009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951551,0.0024787341,0.00015997323,0.0002747923,0.0000811292,0.000026572829,0.00041434946,0.00006202567,0.0013473174],"genre_scores_gemma":[0.99433714,0.0019349857,0.0002486965,0.0001848591,0.000082086444,0.000040495423,0.000634849,0.000019837507,0.0025169924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998047,0.000046368936,0.000014923027,0.000027151455,0.0000176564,0.00008929352],"domain_scores_gemma":[0.9997639,0.000056987963,0.00003248222,0.000029177585,0.000015196753,0.000102125035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002848382,0.00043955288,0.0010593443,0.00050826475,0.00045753876,0.000292381,0.0004937038,0.0008845486,0.0017913916],"category_scores_gemma":[0.00036767,0.00024239294,0.0005065053,0.00021452477,0.00055076357,0.00039626588,0.00019596335,0.0012257834,0.00037110533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045237556,0.0025768685,0.001163505,0.00023205922,0.00012954084,0.0010309779,0.0002335131,0.00039700404,0.9343836,0.0003851475,0.00096523383,0.0132649755],"study_design_scores_gemma":[0.0053561092,0.052132603,0.041347362,0.00007915853,0.0006032177,0.0009346918,0.00050980446,0.0022281406,0.89054435,0.0005398542,0.00562907,0.0000956971],"about_ca_topic_score_codex":0.0026633677,"about_ca_topic_score_gemma":0.003532155,"teacher_disagreement_score":0.0026633677,"about_ca_system_score_codex":0.00038865863,"about_ca_system_score_gemma":0.00032760366,"threshold_uncertainty_score":0.00599277},"labels":[],"label_agreement":null},{"id":"W2337810313","doi":"10.1007/s10557-016-6660-7","title":"Baduanjin Exercise Prevents post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER trial): Design and Rationale of a Pragmatic Randomized Controlled Trial","year":2016,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Biofield Effects and Biophysics","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Myocardial infarction; Heart failure; Ventricular remodeling; Cardiology; Internal medicine; Adverse effect; Clinical endpoint; Physical therapy; Clinical trial; Randomized controlled trial; Rehabilitation","score_opus":0.011565398625210345,"score_gpt":0.2330031030010894,"score_spread":0.22143770437587906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337810313","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7160608,0.037462782,0.022515949,0.00961247,0.009824755,0.18112138,0.0044409474,0.0008717342,0.018089304],"genre_scores_gemma":[0.81916785,0.0054387897,0.023916628,0.007857548,0.00297255,0.13151571,0.0012574606,0.000101631864,0.0077718655],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99194264,0.006019239,0.00046228542,0.0006816913,0.00030882846,0.00058529095],"domain_scores_gemma":[0.99753726,0.0010947785,0.00040437182,0.00028763432,0.00021017021,0.00046585672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00973188,0.0040144227,0.009948679,0.00082561735,0.0012689716,0.0024838757,0.001609495,0.0049919025,0.010404533],"category_scores_gemma":[0.009003518,0.0016306364,0.0046523116,0.00092532363,0.0027884394,0.0021686163,0.0015189223,0.0044807126,0.0016799571],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98453104,0.0018385891,0.00045745767,0.0019757939,0.0029807293,0.000057581772,0.000050469833,0.00032076435,0.00077668997,0.00085143204,0.0005538816,0.005605533],"study_design_scores_gemma":[0.984814,0.011334024,0.0004175585,0.00008995044,0.0015963907,0.0000134802385,0.000021399237,0.00028544915,0.00007694236,0.00067023234,0.0006623684,0.00001832975],"about_ca_topic_score_codex":0.000898776,"about_ca_topic_score_gemma":0.0015918511,"teacher_disagreement_score":0.010404533,"about_ca_system_score_codex":0.000869621,"about_ca_system_score_gemma":0.0014375842,"threshold_uncertainty_score":0.051467657},"labels":[],"label_agreement":null},{"id":"W2594375289","doi":"10.1007/s10557-017-6720-7","title":"Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?","year":2017,"lang":"en","type":"letter","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Heart and Stroke Foundation","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Acute coronary syndrome; Cardiology; Internal medicine; Interventional cardiology; Myocardial infarction","score_opus":0.014604659998805131,"score_gpt":0.25725052707838986,"score_spread":0.24264586707958472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594375289","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055697764,0.0019224684,0.000047907215,0.99143183,0.003414034,0.000004578745,0.00003009989,0.000008082168,0.002584048],"genre_scores_gemma":[0.009650004,0.005334911,0.00038592506,0.93631375,0.045836937,0.00002498021,0.00004501273,0.0000117598665,0.0023967866],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962649,0.0015022969,0.00067538535,0.00024898222,0.000943194,0.00036515633],"domain_scores_gemma":[0.9817941,0.012212076,0.0016562323,0.00030603228,0.002294393,0.0017371431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036464774,0.0004625315,0.001362812,0.0006514666,0.0018655502,0.0030757308,0.0011270129,0.031984016,0.0066988547],"category_scores_gemma":[0.041775715,0.0004183129,0.001063325,0.00090635463,0.0019970813,0.0034876843,0.0010602312,0.023689393,0.0043796226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002579693,0.0001945018,0.005841198,0.00022253426,0.00007448209,0.003396913,0.00020462359,0.00017308639,0.00024247383,0.0071029942,0.899162,0.08312715],"study_design_scores_gemma":[0.00066140253,0.00036996225,0.0074212863,0.002001298,0.00022383752,0.0054097907,0.00092926796,0.0012472075,0.00040454848,0.031943846,0.94926596,0.00012159579],"about_ca_topic_score_codex":0.004312341,"about_ca_topic_score_gemma":0.011147456,"teacher_disagreement_score":0.031984016,"about_ca_system_score_codex":0.0035759844,"about_ca_system_score_gemma":0.0055177687,"threshold_uncertainty_score":0.025945663},"labels":[],"label_agreement":null},{"id":"W2611527891","doi":"10.1007/s10557-017-6727-0","title":"Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries","year":2017,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"Amgen","keywords":"Medicine; Identification (biology); Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Clinical Practice; Extension (predicate logic); Intensive care medicine; Family medicine; Physical therapy; Internal medicine","score_opus":0.035596643869430726,"score_gpt":0.3588116334777675,"score_spread":0.3232149896083368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611527891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988337,0.00012388434,0.0000625697,0.00008988324,0.000004301076,0.00009213259,0.00037498804,0.0000023201192,0.00041616417],"genre_scores_gemma":[0.99858886,0.00024017849,0.00037154226,0.0001985037,0.000007927405,0.00012959178,0.0003458265,0.000002517349,0.00011501865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756795,0.0010489319,0.00040725787,0.0003095974,0.00029882416,0.00036737949],"domain_scores_gemma":[0.99408084,0.0009951863,0.0027074676,0.00020218838,0.0011502185,0.0008640681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002902759,0.00023534174,0.00034522277,0.0012941412,0.0006578126,0.001119575,0.000363267,0.0006700136,0.0015214287],"category_scores_gemma":[0.0053393138,0.0004473457,0.0004183807,0.0013861577,0.0005679178,0.0009314735,0.0014084728,0.00067138305,0.0003966627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004355369,0.00012489027,0.99428695,0.0000723862,0.00001709037,0.00010215737,0.0026638722,0.000024924846,0.00015509529,0.000013646426,0.0002238413,0.0022715311],"study_design_scores_gemma":[0.000020532078,0.00029955176,0.98829204,0.00009611283,0.0000126735,0.0003286361,0.009952028,0.00012330602,0.00006958988,0.000008646748,0.00078793085,0.000008900736],"about_ca_topic_score_codex":0.015070999,"about_ca_topic_score_gemma":0.020569175,"teacher_disagreement_score":0.015070999,"about_ca_system_score_codex":0.0011918623,"about_ca_system_score_gemma":0.0019846351,"threshold_uncertainty_score":0.029966593},"labels":[],"label_agreement":null},{"id":"W2616265690","doi":"10.1007/s10557-017-6728-z","title":"Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect","year":2017,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Duke Clinical Research Institute; Medical Research Council; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Apixaban; Atrial fibrillation; Meta-analysis; Placebo; Internal medicine; Cardiology; Cause of death; Warfarin; Rivaroxaban; Pathology; Disease; Alternative medicine","score_opus":0.10475193296759693,"score_gpt":0.3708094818141447,"score_spread":0.26605754884654775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616265690","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02172137,0.9720302,0.00346397,0.00031204018,0.0006779307,0.0002466457,0.00068038,0.000114755836,0.00075266865],"genre_scores_gemma":[0.58841425,0.39911145,0.006501425,0.001644372,0.00087233295,0.00066518644,0.0014913046,0.00010904978,0.001190588],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9926104,0.004255045,0.0014746097,0.00090699084,0.00051213935,0.00024085547],"domain_scores_gemma":[0.9912902,0.006937795,0.0008616991,0.00052313466,0.0002874225,0.00009971658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010335081,0.0030452542,0.01613546,0.0018260481,0.00043710563,0.0024029412,0.002277337,0.00242456,0.0043938505],"category_scores_gemma":[0.020593096,0.0017341247,0.039485343,0.0019221571,0.000612496,0.0019886617,0.0012202843,0.0042474456,0.00038498855],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019641826,0.000056983685,0.0021688996,0.06409615,0.8999126,0.000095375486,0.00003706847,0.0006998133,0.0003348504,0.000170129,0.00032849595,0.012457854],"study_design_scores_gemma":[0.0042469767,0.0004211034,0.0020652742,0.0015096279,0.9901356,0.00004954269,0.000016738328,0.00032058122,0.000107223874,0.00034168857,0.00076849293,0.000017095519],"about_ca_topic_score_codex":0.0024571796,"about_ca_topic_score_gemma":0.0041506384,"teacher_disagreement_score":0.01613546,"about_ca_system_score_codex":0.0010444456,"about_ca_system_score_gemma":0.0009809036,"threshold_uncertainty_score":0.054657817},"labels":[],"label_agreement":null},{"id":"W2619446181","doi":"10.1007/s10557-017-6729-y","title":"The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease","year":2017,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Heart and Stroke Foundation","funders":"","keywords":"Medicine; Mace; Empagliflozin; Coronary artery disease; Diabetes mellitus; Intensive care medicine; Clinical trial; Revascularization; Internal medicine; Type 2 Diabetes Mellitus; Type 2 diabetes; Disease; Cardiology; Population; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.01138825684342383,"score_gpt":0.2428716451420452,"score_spread":0.23148338829862136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619446181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094760406,0.9994141,0.000042041735,0.00014398353,0.00008427466,0.00000294914,0.000015513118,0.0000022266415,0.00020018083],"genre_scores_gemma":[0.0007955845,0.9985989,0.00013269906,0.00023196293,0.0001275017,0.000004487208,0.00002200805,7.7506087e-7,0.000086118576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967086,0.00006327939,0.000091631766,0.000047844478,0.000102412894,0.000024025798],"domain_scores_gemma":[0.9993175,0.00041107505,0.00014973487,0.000011019796,0.00008508162,0.000025630447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010377018,0.0008335404,0.0024542278,0.0014694653,0.0001385394,0.00093860866,0.0009139891,0.0009638104,0.0030183038],"category_scores_gemma":[0.0014532931,0.0002791074,0.001288998,0.0015679507,0.0003279549,0.0009795079,0.0006509632,0.0021134657,0.00058871845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004055084,0.000100839454,0.00034906474,0.053465426,0.001113698,0.00012717018,0.000044678283,0.00026431415,0.00060038787,0.0014144932,0.013691165,0.92842317],"study_design_scores_gemma":[0.0010037277,0.0007907238,0.007487754,0.048969403,0.008034244,0.0016971545,0.00017368188,0.0005681167,0.0008262906,0.004155529,0.92618436,0.00010909537],"about_ca_topic_score_codex":0.0010469276,"about_ca_topic_score_gemma":0.0028958926,"teacher_disagreement_score":0.0030183038,"about_ca_system_score_codex":0.0003503277,"about_ca_system_score_gemma":0.0010074942,"threshold_uncertainty_score":0.010097206},"labels":[],"label_agreement":null},{"id":"W2682084364","doi":"10.1007/s10557-014-6515-z","title":"Erratum to: Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody","year":2014,"lang":"en","type":"erratum","venue":"Cardiovascular Drugs and Therapy","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University","funders":"National Natural Science Foundation of China; Heart and Stroke Foundation of Canada","keywords":"Medicine; Monoclonal antibody; Antibody; Cardiac allograft vasculopathy; Monoclonal; Immunology; Cancer research; Transplantation; Internal medicine; Heart transplantation","score_opus":0.008999111435308805,"score_gpt":0.25481407905731646,"score_spread":0.24581496762200766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2682084364","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046658836,0.0034150777,0.00036606527,0.0535521,0.938097,0.000036100002,0.00024223006,0.0001202387,0.003704632],"genre_scores_gemma":[0.015208176,0.026390946,0.004003367,0.18971656,0.5023527,0.00019211853,0.0013498702,0.00048079382,0.26030535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979658,0.00022920124,0.00045859467,0.00021388369,0.0009022573,0.00023022386],"domain_scores_gemma":[0.9934521,0.0019029126,0.0006762995,0.00036715594,0.003125685,0.0004757658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021600833,0.0020946495,0.001772504,0.0030203203,0.0022453964,0.0020578082,0.0024226268,0.009512745,0.015413548],"category_scores_gemma":[0.014039844,0.0013055432,0.0016747309,0.0013419221,0.0015374566,0.0016343271,0.0011460776,0.007439874,0.013988498],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115080366,0.000037601116,0.00020057149,0.0001823558,0.000028007176,0.0016414206,0.00001950456,0.00006254807,0.00020769655,0.00045525216,0.9873169,0.009733094],"study_design_scores_gemma":[0.00008436425,0.0000795617,0.0014987887,0.00030306014,0.00012897559,0.0021717339,0.00007581152,0.0003137362,0.0011380211,0.00060434896,0.9935621,0.00003965118],"about_ca_topic_score_codex":0.006476615,"about_ca_topic_score_gemma":0.009104728,"teacher_disagreement_score":0.015413548,"about_ca_system_score_codex":0.0034590024,"about_ca_system_score_gemma":0.0031601172,"threshold_uncertainty_score":0.05156344},"labels":[],"label_agreement":null},{"id":"W2753755248","doi":"10.1007/s10557-017-6750-1","title":"Recent Insights into Pharmacologic Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus","year":2017,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Medicine; Diabetes mellitus; Dyslipidemia; Blood pressure; Glycated hemoglobin; Internal medicine; Type 2 diabetes; PCSK9; Type 2 Diabetes Mellitus; Statin; Myocardial infarction; Stroke (engine); Endocrinology; Cardiology; Cholesterol; Lipoprotein","score_opus":0.04689214265877351,"score_gpt":0.31346270388519376,"score_spread":0.26657056122642026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753755248","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008667146,0.9991289,0.00007052525,0.00018537423,0.000114913164,0.00000499641,0.00001654848,0.0000040021596,0.00038810092],"genre_scores_gemma":[0.0005951809,0.9986003,0.00017980237,0.00029328218,0.00016299592,0.000006720982,0.000018307928,9.346572e-7,0.00014247811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997297,0.000055649958,0.00006618624,0.000043920798,0.0000803624,0.000024269437],"domain_scores_gemma":[0.99934536,0.00041963803,0.00010422054,0.000012361319,0.000091056776,0.000027393315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007599073,0.00086421415,0.0023105347,0.0016496732,0.00019411986,0.0010496111,0.0008786961,0.0009346682,0.0047536884],"category_scores_gemma":[0.0015155656,0.00034356798,0.0011236913,0.0015188927,0.0003460937,0.001075304,0.00068196293,0.0024540992,0.0009766341],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023566154,0.00015640074,0.00021143994,0.043134004,0.00045458492,0.00011951267,0.000045287507,0.00020551472,0.00075884553,0.0015129533,0.013405737,0.9397601],"study_design_scores_gemma":[0.00048758354,0.0006378263,0.003359599,0.029681401,0.0035041778,0.0013161154,0.00014081402,0.00034344528,0.00067955075,0.003586297,0.9561973,0.00006595618],"about_ca_topic_score_codex":0.0010855399,"about_ca_topic_score_gemma":0.002603397,"teacher_disagreement_score":0.0047536884,"about_ca_system_score_codex":0.00034771574,"about_ca_system_score_gemma":0.0008187193,"threshold_uncertainty_score":0.015902638},"labels":[],"label_agreement":null},{"id":"W2758676322","doi":"10.1007/s10557-017-6754-x","title":"Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes","year":2017,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"AstraZeneca","keywords":"Medicine; Prediabetes; Diabetes mellitus; Internal medicine; Cardiology; Type 2 diabetes; Intensive care medicine; Endocrinology","score_opus":0.012760804297408767,"score_gpt":0.26726321343082743,"score_spread":0.25450240913341865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758676322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989507,0.00036307028,0.000047903024,0.00005578187,0.0000044053863,0.0000052669634,0.00026498034,0.000002011942,0.00030597427],"genre_scores_gemma":[0.9995401,0.000075290234,0.000044896067,0.000025279507,0.000012773092,0.000004655051,0.00024698421,4.5400728e-7,0.000049553113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940765,0.00016602845,0.000075053875,0.000104634564,0.0001358936,0.000110752895],"domain_scores_gemma":[0.99799937,0.00032795986,0.0010482592,0.00009548729,0.00015615376,0.0003727023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084953336,0.00019287871,0.00027230047,0.0007901554,0.00029186413,0.0004660235,0.00029668288,0.00043742865,0.00106512],"category_scores_gemma":[0.002733243,0.00017528067,0.00032315447,0.00066480675,0.00025573806,0.0003735931,0.00045692705,0.00068187324,0.00009870566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030715408,0.00001386574,0.9995586,0.000002551099,0.000014743909,0.000016074418,0.000007946282,0.0000088066345,0.000011956207,0.0000045759302,0.000017817636,0.00031214865],"study_design_scores_gemma":[0.0000043425953,0.00003487895,0.9996301,0.0000032156902,0.000008854975,0.00014475865,0.000040839463,0.000078358804,0.000009288541,0.000011942349,0.000031964537,0.0000014084073],"about_ca_topic_score_codex":0.006814441,"about_ca_topic_score_gemma":0.007980275,"teacher_disagreement_score":0.006814441,"about_ca_system_score_codex":0.0003139479,"about_ca_system_score_gemma":0.00038638356,"threshold_uncertainty_score":0.013549566},"labels":[],"label_agreement":null},{"id":"W2767565660","doi":"10.1007/s10557-017-6759-5","title":"Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review","year":2017,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Medicine; Chelation therapy; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.22014899107175834,"score_gpt":0.41294519255444584,"score_spread":0.1927962014826875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767565660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063553394,0.99941504,0.000052930565,0.00017288954,0.000059029844,0.0000047269627,0.000014786834,0.0000020346977,0.00021501866],"genre_scores_gemma":[0.0005655935,0.9988563,0.00014120426,0.00021353479,0.000089836074,0.0000066830858,0.000015110315,7.272982e-7,0.000111062094],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99965894,0.000073554955,0.00008455085,0.00006355775,0.00009611222,0.000023158758],"domain_scores_gemma":[0.9988991,0.00071471906,0.0001722133,0.00002154715,0.00015629841,0.000036103687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010380805,0.0010026342,0.0030206393,0.0023694828,0.00028985864,0.0015565746,0.0012664661,0.0013879217,0.0036028274],"category_scores_gemma":[0.001727513,0.00031942155,0.001106992,0.0022631914,0.0006920848,0.0014485222,0.0007631588,0.0020850732,0.0009216922],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003823198,0.00015891716,0.00038934205,0.11251178,0.0006119716,0.0003402528,0.00009066215,0.00045302423,0.0020245018,0.0045390236,0.020044183,0.85845405],"study_design_scores_gemma":[0.00017110424,0.00038246828,0.0015366051,0.035180807,0.0024434575,0.0028920718,0.00019114779,0.00025338138,0.0012196583,0.0045029153,0.95116687,0.0000594238],"about_ca_topic_score_codex":0.00087311224,"about_ca_topic_score_gemma":0.0023124886,"teacher_disagreement_score":0.0036028274,"about_ca_system_score_codex":0.00058676256,"about_ca_system_score_gemma":0.0018440018,"threshold_uncertainty_score":0.012052655},"labels":[],"label_agreement":null},{"id":"W2796976049","doi":"10.1007/s10557-018-6785-y","title":"Old Drugs for New Indications in Cardiovascular Medicine","year":2018,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Allopurinol; Intensive care medicine; Disease; Canakinumab; Inflammation; Colchicine; Clinical trial; Methotrexate; Bioinformatics; Pharmacology; Anakinra; Internal medicine","score_opus":0.021036498599712548,"score_gpt":0.28249481899775264,"score_spread":0.26145832039804007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796976049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007987333,0.9974356,0.00022517634,0.00060709164,0.0005647788,0.000004938004,0.000022100188,0.0000103639095,0.0010499808],"genre_scores_gemma":[0.000885326,0.9959174,0.00035930253,0.00084415777,0.0010022346,0.000009266477,0.000038138158,0.0000032163073,0.000941024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974734,0.000054066466,0.000040255836,0.000037699254,0.00009536251,0.000025215111],"domain_scores_gemma":[0.99942636,0.0003205636,0.00007005843,0.00002328286,0.00010548667,0.00005427814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073567487,0.0008186856,0.0015350883,0.0017977622,0.00028888916,0.0012072277,0.0008617016,0.0013951688,0.0052370476],"category_scores_gemma":[0.0012490596,0.00026541675,0.00046968716,0.00162548,0.00081167213,0.001773573,0.0008948556,0.0032946859,0.0019027367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013254359,0.00010016429,0.00018173493,0.010132566,0.00008920987,0.00032631087,0.000060998802,0.00035842374,0.0015724562,0.008377591,0.057982203,0.9206858],"study_design_scores_gemma":[0.00004032322,0.00007726874,0.00037976648,0.0022192243,0.00008841611,0.00091333594,0.00004108689,0.00011702657,0.00023952234,0.0042149536,0.9916529,0.000016057606],"about_ca_topic_score_codex":0.00043367324,"about_ca_topic_score_gemma":0.0013397583,"teacher_disagreement_score":0.0052370476,"about_ca_system_score_codex":0.00046542552,"about_ca_system_score_gemma":0.00096818944,"threshold_uncertainty_score":0.017519653},"labels":[],"label_agreement":null},{"id":"W2808249085","doi":"10.1007/s10557-018-6798-6","title":"Food as Medicine for Secondary Prevention of Cardiovascular Events Following an Acute Coronary Syndrome","year":2018,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Diet and metabolism studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Medicine; Acute coronary syndrome; Diabetes mellitus; Weight loss; Internal medicine; Meal; Calorie; Hyperlipidemia; Intensive care medicine; Myocardial infarction; Obesity; Endocrinology","score_opus":0.020613885434325605,"score_gpt":0.282395138689194,"score_spread":0.2617812532548684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808249085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8749831,0.11309765,0.00034858976,0.0013019576,0.0005735652,0.00021690884,0.0005107793,0.00001778894,0.008949692],"genre_scores_gemma":[0.9714002,0.024663426,0.00073102146,0.0007451823,0.00035847543,0.00005410787,0.0002119595,0.000005852746,0.0018297057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984855,0.0011209764,0.00008930873,0.000092213406,0.00012410434,0.000087872155],"domain_scores_gemma":[0.99790215,0.0011724214,0.00042435896,0.00012247532,0.00015536186,0.00022327666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024956272,0.0007821155,0.0011179849,0.00138666,0.0006291431,0.0012186628,0.0003795224,0.0012486463,0.0044233794],"category_scores_gemma":[0.0029361688,0.0003152923,0.0015091246,0.0011068786,0.00047572865,0.0006032999,0.00058778666,0.0010235738,0.00025447234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25674105,0.019637479,0.46331176,0.010302858,0.020725116,0.0009541448,0.0009074815,0.00033424134,0.010635925,0.0029311886,0.0025800094,0.21093874],"study_design_scores_gemma":[0.0089181075,0.08608685,0.850612,0.001736931,0.027251538,0.0007100397,0.00076450803,0.00047146218,0.004437181,0.0018537523,0.017078023,0.0000797322],"about_ca_topic_score_codex":0.0012824099,"about_ca_topic_score_gemma":0.0033786783,"teacher_disagreement_score":0.0044233794,"about_ca_system_score_codex":0.00037072785,"about_ca_system_score_gemma":0.0007191237,"threshold_uncertainty_score":0.0147976875},"labels":[],"label_agreement":null},{"id":"W285554971","doi":"10.1023/a:1007886725480","title":"Endothelial Dysfunction in Hypercholesterolemia is Reversed by a Nutritional Product Designed to Enhance Nitric Oxide Activity","year":2000,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cooke Aquaculture (Canada)","funders":"","keywords":"Medicine; Vasodilation; Endothelium; Placebo; Nitric oxide; Internal medicine; Endothelial dysfunction; Pharmacology; Endocrinology; Pathology","score_opus":0.008485052256925495,"score_gpt":0.24206626762694328,"score_spread":0.23358121537001778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W285554971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481684,0.0021647897,0.0011808057,0.0002927288,0.0001321263,0.000032104024,0.00008930585,0.000103312654,0.0011880144],"genre_scores_gemma":[0.9929095,0.0018629563,0.0023268417,0.0002482883,0.000093415314,0.000048324677,0.00022946473,0.00002491513,0.002256241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999088,0.00002625398,0.0000121414005,0.000010038598,0.00001754254,0.000025162077],"domain_scores_gemma":[0.9998437,0.000026475738,0.000028543514,0.000019250325,0.000014421197,0.00006759894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023805162,0.00047236498,0.0006703249,0.00035370403,0.00031133063,0.00022710334,0.00028154484,0.00046856026,0.0015804673],"category_scores_gemma":[0.00035488216,0.00025571103,0.00029279612,0.00021533712,0.00039135883,0.00025686217,0.00022143856,0.001154291,0.0003057725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032249585,0.0021621303,0.001425081,0.00023154421,0.00011522209,0.000601262,0.000067806024,0.000083533705,0.9384535,0.0004607908,0.00040510015,0.023744445],"study_design_scores_gemma":[0.0059499256,0.02164847,0.03639754,0.000057513793,0.0005202119,0.0014325017,0.00012345161,0.0013605176,0.9266466,0.0005133042,0.005313739,0.000036313544],"about_ca_topic_score_codex":0.0007503461,"about_ca_topic_score_gemma":0.0012730004,"teacher_disagreement_score":0.0015804673,"about_ca_system_score_codex":0.00014353347,"about_ca_system_score_gemma":0.00033142898,"threshold_uncertainty_score":0.00528723},"labels":[],"label_agreement":null},{"id":"W2886129529","doi":"10.1007/s10557-018-6816-8","title":"Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus","year":2018,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"Amgen","keywords":"Medicine; Statin; Rosuvastatin; Diabetes mellitus; Myocardial infarction; Atorvastatin; Internal medicine; Intensity (physics); Pharmacy; Cardiology; Endocrinology","score_opus":0.006761172454070548,"score_gpt":0.22533713733122956,"score_spread":0.21857596487715902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886129529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772626,0.00090690126,0.00008194917,0.00016872416,0.000051542393,0.000045649962,0.00010405794,0.000006404093,0.0009085309],"genre_scores_gemma":[0.9989046,0.00030314754,0.00012709077,0.0002176444,0.000048720285,0.000024226845,0.00019720523,0.0000017308457,0.00017577925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895334,0.0003673018,0.00015303795,0.00015620347,0.0001908785,0.00017920879],"domain_scores_gemma":[0.9983296,0.00055502006,0.00039284368,0.00009052762,0.00014272395,0.00048933073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011282015,0.00040588126,0.0017732853,0.00064361474,0.0006643245,0.0009889064,0.00048452936,0.0011335922,0.0012303324],"category_scores_gemma":[0.007866124,0.0003271898,0.001088485,0.0008429359,0.00031298204,0.00088705623,0.000674463,0.0013233363,0.00020467077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06356733,0.0020994097,0.89508176,0.0001473525,0.0008198618,0.0005487983,0.00059149513,0.00048896484,0.0016535821,0.000092755465,0.0005253469,0.034383427],"study_design_scores_gemma":[0.000917015,0.0029631348,0.9939715,0.000031832675,0.00025732184,0.00014649345,0.00033539243,0.000814264,0.00012504237,0.00013584021,0.00027386672,0.000028242292],"about_ca_topic_score_codex":0.0039276206,"about_ca_topic_score_gemma":0.0064564142,"teacher_disagreement_score":0.0039276206,"about_ca_system_score_codex":0.00075887726,"about_ca_system_score_gemma":0.0007345361,"threshold_uncertainty_score":0.00780952},"labels":[],"label_agreement":null},{"id":"W2901655499","doi":"10.1007/s10557-018-6840-8","title":"Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction","year":2018,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Amgen","keywords":"Medicine; Statin; Ezetimibe; Discontinuation; Adverse effect; Myocardial infarction; Internal medicine; Emergency medicine","score_opus":0.005418490729975448,"score_gpt":0.23245149411686675,"score_spread":0.2270330033868913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901655499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941527,0.0009649731,0.000046280602,0.00035921583,0.000020787875,0.000009353027,0.0028530362,0.0000054500497,0.0015883163],"genre_scores_gemma":[0.9964713,0.00040576438,0.000047351354,0.00010486279,0.00005680765,0.0000086394075,0.0023320373,0.0000015391005,0.00057180243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995285,0.000089911446,0.0000942352,0.000055968234,0.000103092934,0.0001282661],"domain_scores_gemma":[0.99881685,0.000135346,0.00071759697,0.000031679287,0.000095724215,0.00020276687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031235543,0.00020506867,0.00035231299,0.0009906334,0.00035883786,0.0006343606,0.00026732142,0.0006445675,0.0024038716],"category_scores_gemma":[0.0025110096,0.00023523044,0.0008552114,0.0012833397,0.00012073308,0.00050768256,0.0006882915,0.00073201454,0.0001708648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025602902,0.00004846223,0.9971916,0.000022336262,0.00020341773,0.000084234365,0.000028463515,0.00012346737,0.00009165231,0.00007389622,0.00040810535,0.0014684586],"study_design_scores_gemma":[0.0000055224245,0.000019889274,0.9993487,0.0000071864692,0.000049665152,0.00008032672,0.000050856117,0.00021046815,0.000013042697,0.000020316438,0.00019194893,0.0000020618504],"about_ca_topic_score_codex":0.037076566,"about_ca_topic_score_gemma":0.054143604,"teacher_disagreement_score":0.037076566,"about_ca_system_score_codex":0.0009496151,"about_ca_system_score_gemma":0.00063730264,"threshold_uncertainty_score":0.07372153},"labels":[],"label_agreement":null},{"id":"W2912885478","doi":"10.1007/s10557-019-06864-2","title":"Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria","year":2019,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; U.S. Department of Health and Human Services; National Institutes of Health; Amgen","keywords":"Medicine; Hazard ratio; Internal medicine; Stroke (engine); Myocardial infarction; PCSK9; Clinical trial; Cardiology; Cholesterol; Confidence interval; Lipoprotein","score_opus":0.017528691469809926,"score_gpt":0.28040837125761675,"score_spread":0.2628796797878068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912885478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598396,0.00035241622,0.00019241107,0.000081902785,0.000034345714,0.00015368462,0.0022918442,0.000008046426,0.00090150436],"genre_scores_gemma":[0.99541414,0.00011731751,0.00019838466,0.0001394964,0.00006047287,0.0003470114,0.002938208,0.0000073067677,0.0007776382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993861,0.00016214767,0.00007751535,0.00013183191,0.0000940207,0.00014838667],"domain_scores_gemma":[0.9992405,0.00015127513,0.0002530489,0.000084667525,0.00006977046,0.0002007065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011239033,0.0007374806,0.001424022,0.0007633432,0.00062000676,0.0007755488,0.00051280577,0.0009973632,0.0030514433],"category_scores_gemma":[0.0017279405,0.0005122508,0.0016742145,0.0008465242,0.00034768175,0.0008851582,0.0005348315,0.0011065913,0.00039497152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051175203,0.0014537096,0.93589747,0.00014065971,0.0015467355,0.00025806055,0.00016326993,0.00034401612,0.0015897391,0.00024399968,0.0018689949,0.005318172],"study_design_scores_gemma":[0.0031299593,0.0023109044,0.9917808,0.000018424193,0.00054478383,0.00022792524,0.00021755978,0.00068467815,0.00019854584,0.00021082714,0.00064951787,0.000026014306],"about_ca_topic_score_codex":0.0023188605,"about_ca_topic_score_gemma":0.0038614685,"teacher_disagreement_score":0.0030514433,"about_ca_system_score_codex":0.00025290233,"about_ca_system_score_gemma":0.00040091557,"threshold_uncertainty_score":0.01020807},"labels":[],"label_agreement":null},{"id":"W2942421697","doi":"10.1007/s10557-019-06869-x","title":"Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis","year":2019,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact","funders":"","keywords":"Medicine; Atrial fibrillation; Cardioversion; Meta-analysis; Vitamin k; Cardiology; Internal medicine; Vitamin K antagonist; Rivaroxaban; Anesthesia; Warfarin","score_opus":0.13239395191512476,"score_gpt":0.36393875641580004,"score_spread":0.23154480450067527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942421697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00719313,0.99117446,0.0004494296,0.00014405692,0.00017941669,0.0001730024,0.00043791672,0.000027277654,0.00022134456],"genre_scores_gemma":[0.21554734,0.7785205,0.0022799594,0.0014878727,0.00033626804,0.0005386811,0.00065818935,0.00004346619,0.00058771746],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99612385,0.0013828522,0.0013572776,0.00054496934,0.00038855107,0.00020249536],"domain_scores_gemma":[0.9933809,0.004346152,0.001520535,0.00023640954,0.00038004495,0.00013606863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056470414,0.0024931156,0.016873177,0.0031500629,0.0005287913,0.0026438083,0.001945754,0.0023547525,0.004811965],"category_scores_gemma":[0.013774212,0.00163956,0.032189682,0.004082174,0.00067447615,0.0017710018,0.0016536784,0.0024725643,0.00040364082],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032875196,0.00003750972,0.003566065,0.26969168,0.71252,0.000106011765,0.00008128026,0.00027720438,0.00024757764,0.00009309652,0.00054954377,0.009542434],"study_design_scores_gemma":[0.0010113025,0.0001363949,0.002349703,0.0091821,0.98613864,0.00005264021,0.000035035122,0.00007945631,0.000051410112,0.00010374368,0.00084018084,0.000019423496],"about_ca_topic_score_codex":0.0062674168,"about_ca_topic_score_gemma":0.021590263,"teacher_disagreement_score":0.016873177,"about_ca_system_score_codex":0.0017044378,"about_ca_system_score_gemma":0.0022625236,"threshold_uncertainty_score":0.029864788},"labels":[],"label_agreement":null},{"id":"W2967939814","doi":"10.1007/s10557-019-06900-1","title":"Angiotensin II Type 1 Receptor Antagonist Azilsartan Restores Vascular Reactivity Through a Perivascular Adipose Tissue-Independent Mechanism in Rats with Metabolic Syndrome","year":2019,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Adipose tissue; Internal medicine; Angiotensin II; Endocrinology; Antagonist; Vasoconstrictor Agents; Receptor antagonist; Receptor; Mechanism (biology); Pharmacology; Vasodilation","score_opus":0.009457963170781705,"score_gpt":0.2287295900689482,"score_spread":0.21927162689816648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967939814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430084,0.0009717972,0.002462142,0.0004808525,0.00026673957,0.000025616195,0.00031145578,0.00025855307,0.0009220788],"genre_scores_gemma":[0.9922276,0.0015008415,0.0018542209,0.00022464496,0.00013119054,0.00008986608,0.00041353257,0.000085655345,0.0034724262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969137,0.000058650392,0.000024008586,0.000052368257,0.00005499232,0.000118783304],"domain_scores_gemma":[0.99957436,0.0000302104,0.000100121324,0.000049318653,0.00003466204,0.00021132207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002894033,0.00097607926,0.001222712,0.0007054473,0.00040168548,0.00048007636,0.0005116801,0.0005956965,0.00217782],"category_scores_gemma":[0.0002546034,0.00042971614,0.00063446944,0.00025566982,0.0007123445,0.000614967,0.00034254105,0.0030340075,0.00047286684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018262409,0.001976506,0.0004834007,0.00013069446,0.000104652725,0.00030378447,0.000046526384,0.00021055082,0.9711556,0.00030534592,0.00030641243,0.0067141815],"study_design_scores_gemma":[0.0028326174,0.0155553315,0.02681821,0.00005321003,0.00064689195,0.00057581655,0.0005174581,0.003949732,0.94421405,0.00090032193,0.0038368024,0.000099571575],"about_ca_topic_score_codex":0.000931265,"about_ca_topic_score_gemma":0.0014999333,"teacher_disagreement_score":0.00217782,"about_ca_system_score_codex":0.00032804807,"about_ca_system_score_gemma":0.0005270884,"threshold_uncertainty_score":0.007285595},"labels":[],"label_agreement":null},{"id":"W2971407847","doi":"10.1007/s10557-019-06905-w","title":"Chewed or Crushed Administration of Adenosine Diphosphate Receptor Inhibitors in Acute Coronary Syndromes: a Systematic Review and Meta-analysis of Randomized Controlled Trials","year":2019,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Toronto; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Randomized controlled trial; Pharmacology; Adenosine; Meta-analysis; Internal medicine; Intensive care medicine","score_opus":0.07912530663309206,"score_gpt":0.34945362360990045,"score_spread":0.27032831697680837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971407847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052921684,0.9930628,0.00048235856,0.0001005309,0.00016829756,0.00027942914,0.0003912147,0.000026239788,0.00019701794],"genre_scores_gemma":[0.14946316,0.8442099,0.0030239234,0.0012285106,0.00025300786,0.0006587824,0.00064372114,0.0000396263,0.00047941974],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940164,0.0024832922,0.001898486,0.00075778906,0.00061979966,0.00022412211],"domain_scores_gemma":[0.9912731,0.0058601177,0.0019292375,0.00031347107,0.00046143137,0.0001625761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008147061,0.002627682,0.020788375,0.0035106293,0.0005169708,0.002742226,0.0022155473,0.0023099466,0.0046756826],"category_scores_gemma":[0.017775286,0.0015004284,0.028855149,0.004583377,0.00082493713,0.0018351664,0.0016665981,0.0023985934,0.0003547592],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050448882,0.0000395237,0.0018395721,0.3871425,0.5925792,0.000079323065,0.00007564983,0.00030547968,0.00030019606,0.0001006641,0.00051224424,0.011980818],"study_design_scores_gemma":[0.002396447,0.0002740771,0.0024220885,0.015800932,0.97732955,0.000050181334,0.00004267454,0.000106326625,0.00008297833,0.00015967074,0.0013090279,0.000026146346],"about_ca_topic_score_codex":0.005066977,"about_ca_topic_score_gemma":0.016614776,"teacher_disagreement_score":0.020788375,"about_ca_system_score_codex":0.001733688,"about_ca_system_score_gemma":0.0022384482,"threshold_uncertainty_score":0.04308629},"labels":[],"label_agreement":null},{"id":"W3008777148","doi":"10.1007/s10557-019-06927-4","title":"Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases","year":2020,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Natural Science Foundation of China","keywords":"Autophagy; Medicine; Cell biology; Mechanism (biology); Intracellular; Vasodilation; Disease; Programmed cell death; Neuroscience; Biology; Internal medicine; Biochemistry; Apoptosis","score_opus":0.02377304949383676,"score_gpt":0.27898146413672664,"score_spread":0.2552084146428899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008777148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011306449,0.9989353,0.000083930776,0.00016019364,0.00015858997,0.0000031609088,0.000015619089,0.000006564794,0.0005235813],"genre_scores_gemma":[0.0010114629,0.9979564,0.00012844267,0.00020145912,0.00024880556,0.0000053623994,0.00003304427,9.5419e-7,0.00041407844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998976,0.000017640354,0.000020139229,0.000019738329,0.00003156054,0.000013320514],"domain_scores_gemma":[0.999882,0.000050406074,0.000023335542,0.0000034917941,0.00002749001,0.00001325191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038465677,0.0009230073,0.0016903614,0.0015481064,0.00018312302,0.00093538093,0.00061715156,0.0010188692,0.0024881777],"category_scores_gemma":[0.00040853996,0.0002520877,0.0005556459,0.0014321874,0.00036901468,0.0009824478,0.0007210287,0.0015735856,0.0009953424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028257526,0.00009778615,0.00022999491,0.027696686,0.00025069498,0.0002481318,0.00004439697,0.00036252185,0.0031788205,0.0031882718,0.03096067,0.9334596],"study_design_scores_gemma":[0.00017763855,0.0003197622,0.0021095453,0.0058764694,0.00091658195,0.0013900253,0.00007852239,0.00048764658,0.0018088176,0.004720838,0.98205906,0.000055197997],"about_ca_topic_score_codex":0.0007830372,"about_ca_topic_score_gemma":0.0018804461,"teacher_disagreement_score":0.0024881777,"about_ca_system_score_codex":0.00048623132,"about_ca_system_score_gemma":0.000779836,"threshold_uncertainty_score":0.008323729},"labels":[],"label_agreement":null},{"id":"W3026424759","doi":"10.1007/s10557-020-06979-x","title":"Major Cardiac–Psychiatric Drug–Drug Interactions: a Systematic Review of the Consistency of Drug Databases","year":2020,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Pfizer","keywords":"Medicine; Torsades de pointes; Cardiotoxicity; Major depressive disorder; Drug; Drug interaction; Dyslipidemia; Psychiatry; Cardiac arrhythmia; Drug class; Intensive care medicine; Pharmacology; Database; QT interval; Disease; Internal medicine; Atrial fibrillation; Mood","score_opus":0.030347514279430658,"score_gpt":0.3362891563376259,"score_spread":0.30594164205819524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026424759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002274379,0.99429893,0.00038652917,0.0003871951,0.00009706898,0.00014069627,0.002144528,0.000015112618,0.00025550943],"genre_scores_gemma":[0.060640942,0.93262494,0.0027651158,0.0015363198,0.00012640128,0.0004004679,0.0017660871,0.000030410576,0.00010936552],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96218544,0.011501708,0.01831498,0.0034451939,0.004103535,0.00044913872],"domain_scores_gemma":[0.8444843,0.11800139,0.027735887,0.003256146,0.0058041103,0.00071815937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023177912,0.0012719404,0.009857551,0.01511516,0.00061156583,0.0032038991,0.0028358356,0.0017983958,0.003937623],"category_scores_gemma":[0.1161743,0.0014030247,0.011559364,0.017437762,0.0013549383,0.0039216853,0.0032402372,0.0017847262,0.0002838739],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044949452,0.000018588737,0.0077023567,0.87134933,0.07167843,0.00011921841,0.00035494738,0.00023503935,0.00018776287,0.000564857,0.0026151633,0.04472475],"study_design_scores_gemma":[0.00056207605,0.00015986027,0.024282519,0.60950327,0.3321966,0.00066957396,0.0005492758,0.0002633301,0.00028429032,0.0010353103,0.03038122,0.00011268209],"about_ca_topic_score_codex":0.009677475,"about_ca_topic_score_gemma":0.036230568,"teacher_disagreement_score":0.023177912,"about_ca_system_score_codex":0.0030976848,"about_ca_system_score_gemma":0.008876434,"threshold_uncertainty_score":0.122577965},"labels":[],"label_agreement":null},{"id":"W3031133260","doi":"10.1007/s10557-020-07012-x","title":"Aspirin Discontinuation in Patients Requiring Oral Anticoagulation Undergoing Percutaneous Coronary Intervention, The Role of Procedural Complexity","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Conventional PCI; Aspirin; Discontinuation; Percutaneous coronary intervention; Cardiology; Antithrombotic; Internal medicine; Platelet aggregation inhibitor; Myocardial infarction; Surgery","score_opus":0.04891841505474018,"score_gpt":0.2828039735181581,"score_spread":0.23388555846341794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031133260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682745,0.018102076,0.00035148408,0.005754315,0.00019813732,0.00003300828,0.00031033423,0.000007221304,0.006968956],"genre_scores_gemma":[0.9957416,0.0026363672,0.00021078037,0.00039109524,0.00051561743,0.000007385068,0.00019019659,0.0000039814004,0.0003029728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986034,0.00042626675,0.00025150125,0.00017418622,0.00036435467,0.00018025894],"domain_scores_gemma":[0.9895802,0.004508884,0.0042293672,0.0003323663,0.00041630186,0.00093284063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013274419,0.00020779869,0.00057864736,0.00064151204,0.00064906565,0.002284723,0.00042552728,0.000948309,0.0024111657],"category_scores_gemma":[0.021820841,0.00022266227,0.0010506781,0.00092349644,0.00031718716,0.0013242338,0.0007310511,0.0017751541,0.00013065252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043137444,0.00007916372,0.984614,0.00006145482,0.00027597748,0.0002448432,0.00015563492,0.00009204089,0.00006252453,0.0002578642,0.00045503123,0.013270064],"study_design_scores_gemma":[0.00003547974,0.000080859136,0.9965946,0.00009223762,0.0001875445,0.00075423974,0.00033246467,0.0005124516,0.000023592222,0.0006162161,0.0007590676,0.00001134257],"about_ca_topic_score_codex":0.004315145,"about_ca_topic_score_gemma":0.008057143,"teacher_disagreement_score":0.004315145,"about_ca_system_score_codex":0.0006866768,"about_ca_system_score_gemma":0.0013891812,"threshold_uncertainty_score":0.008580029},"labels":[],"label_agreement":null},{"id":"W3039424678","doi":"10.1007/s10557-020-06988-w","title":"Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"CYP2C19; Pharmacogenomics; Medicine; Clopidogrel; Allele; Genetics; Compound heterozygosity; Genetic variation; DNA sequencing; Bioinformatics; Gene; Internal medicine; Genotype; Pharmacology; Aspirin; Biology","score_opus":0.12637154550655566,"score_gpt":0.29688151932353674,"score_spread":0.17050997381698108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039424678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80387634,0.05883159,0.07328935,0.032350052,0.0022266344,0.00022268457,0.015858525,0.0007183483,0.0126264775],"genre_scores_gemma":[0.9086703,0.012660435,0.054128777,0.011373694,0.0025905175,0.0001358471,0.007426421,0.00023761396,0.0027764314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981913,0.0008600536,0.00013167606,0.000375186,0.00032990339,0.00011182942],"domain_scores_gemma":[0.9938992,0.004001431,0.00075242406,0.00033381657,0.0006536095,0.00035933786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003470585,0.00063685,0.0010817343,0.0014792595,0.00028798167,0.0014688063,0.0007766385,0.0018823876,0.0022537487],"category_scores_gemma":[0.009282683,0.00029488347,0.0008564044,0.0015325265,0.00040438047,0.00064927485,0.00046433762,0.0015519097,0.00050376274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00397253,0.0007210462,0.42362162,0.0011823477,0.0030368834,0.0034758667,0.0005618406,0.0135606155,0.10526024,0.011298794,0.04345926,0.38984886],"study_design_scores_gemma":[0.0010672336,0.0018001987,0.6521795,0.0013328289,0.0035211844,0.010948553,0.0006005881,0.06834954,0.054431196,0.05000749,0.15546039,0.00030138352],"about_ca_topic_score_codex":0.0028241326,"about_ca_topic_score_gemma":0.005760074,"teacher_disagreement_score":0.003470585,"about_ca_system_score_codex":0.0005690964,"about_ca_system_score_gemma":0.00085837825,"threshold_uncertainty_score":0.018354416},"labels":[],"label_agreement":null},{"id":"W3047446147","doi":"10.1007/s10557-020-07047-0","title":"Beneficial Effects of Baduanjin Exercise on Left Ventricular Remodelling in Patients after Acute Myocardial Infarction: an Exploratory Clinical Trial and Proteomic Analysis","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Biofield Effects and Biophysics","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Myocardial infarction; Cardiology; Internal medicine; Ventricular remodeling; Clinical endpoint; Revascularization; Ejection fraction; Randomized controlled trial; Heart failure","score_opus":0.015432707675055222,"score_gpt":0.25384476359981967,"score_spread":0.23841205592476444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047446147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771273,0.0014851512,0.00008531089,0.00008474221,0.000048797203,0.00013733562,0.00008286408,0.0000049374503,0.00035812458],"genre_scores_gemma":[0.9974716,0.0010146215,0.00026150365,0.0002313842,0.000121803874,0.0002700472,0.00024158026,0.0000026764021,0.00038494804],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997286,0.00009522223,0.000020945216,0.000066745815,0.00002598563,0.000062411775],"domain_scores_gemma":[0.9997495,0.00005064338,0.000042429696,0.000024000412,0.0000222034,0.000111333815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008454134,0.0008074155,0.0018068969,0.00022286618,0.00052307895,0.0008229786,0.0003190469,0.000816991,0.0015378665],"category_scores_gemma":[0.00052634685,0.0002938448,0.0009757371,0.0003794918,0.0006794572,0.00043792784,0.00044262334,0.0009879217,0.00019758721],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8178526,0.03065552,0.066233665,0.0012609005,0.00429062,0.0002511726,0.00027184823,0.00050374825,0.02686673,0.00018295097,0.00043247524,0.051197745],"study_design_scores_gemma":[0.17317906,0.32732868,0.47860977,0.00020041305,0.010246028,0.0002265441,0.0006355844,0.0012000115,0.0051956507,0.00063351355,0.0024327175,0.0001119446],"about_ca_topic_score_codex":0.00031047373,"about_ca_topic_score_gemma":0.00060046656,"teacher_disagreement_score":0.0018068969,"about_ca_system_score_codex":0.00020172262,"about_ca_system_score_gemma":0.00042637793,"threshold_uncertainty_score":0.0051446557},"labels":[],"label_agreement":null},{"id":"W3049639185","doi":"10.1007/s10557-020-07046-1","title":"Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Impact; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Medical prescription; Pharmacy; Drug class; Drug; Prescription drug; Medical emergency; Emergency medicine; Family medicine; Intensive care medicine; Pharmacology","score_opus":0.02860362099114079,"score_gpt":0.2767855050177058,"score_spread":0.24818188402656505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049639185","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14488728,0.04051995,0.0025265727,0.7069075,0.004669473,0.00072307617,0.005334086,0.0004581684,0.093973815],"genre_scores_gemma":[0.8124581,0.03237176,0.0133236805,0.11708074,0.0030119,0.00064757036,0.0033310154,0.00009400826,0.01768123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789125,0.00035332068,0.00013336027,0.000101876896,0.00068413257,0.00083604525],"domain_scores_gemma":[0.99208426,0.00060649775,0.0006439028,0.00006920805,0.0028860406,0.0037101004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020940804,0.0005368446,0.0007336707,0.0020259744,0.003812887,0.0028683355,0.002389759,0.002342573,0.012107353],"category_scores_gemma":[0.013138306,0.00028988105,0.0019104758,0.0020426405,0.0005990195,0.0012067138,0.0018820103,0.0035421837,0.00045355587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005084474,0.0023248768,0.10213165,0.0021822313,0.0007683677,0.0005837715,0.0020821537,0.0021350412,0.00053127535,0.009735396,0.4197243,0.4572926],"study_design_scores_gemma":[0.0017318419,0.0007108881,0.6003709,0.009055875,0.0014081789,0.0006537402,0.0113732675,0.008930347,0.00049973844,0.0076946495,0.35722518,0.0003454447],"about_ca_topic_score_codex":0.9578992,"about_ca_topic_score_gemma":0.9742149,"teacher_disagreement_score":0.042100787,"about_ca_system_score_codex":0.03136131,"about_ca_system_score_gemma":0.13765231,"threshold_uncertainty_score":0.2275433},"labels":[],"label_agreement":null},{"id":"W3086236978","doi":"10.1007/s10557-020-07064-z","title":"Spermine Protects Cardiomyocytes from High Glucose-Induced Energy Disturbance by Targeting the CaSR-gp78-Ubiquitin Proteasome System","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University","funders":"National Natural Science Foundation of China; Heilongjiang Postdoctoral Science Foundation","keywords":"Spermine; MFN2; MFN1; Downregulation and upregulation; Internal medicine; Endocrinology; Mitochondrion; Cell biology; Biology; Medicine; mitochondrial fusion; Biochemistry","score_opus":0.007551836849468558,"score_gpt":0.18919331628299957,"score_spread":0.181641479433531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086236978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98747766,0.0075191273,0.0023641195,0.00035456248,0.00014986191,0.000026791615,0.00022058211,0.0002579208,0.0016293627],"genre_scores_gemma":[0.99421245,0.0023476302,0.0007955648,0.00007754032,0.000029847166,0.00001547336,0.00022977966,0.000024130804,0.0022676622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999187,0.000013533432,0.000009176761,0.00001702599,0.00001546575,0.000026060214],"domain_scores_gemma":[0.9999285,0.00000770368,0.000025967287,0.0000108346185,0.000008605968,0.00001843813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001547585,0.00039346435,0.00043497497,0.0001720609,0.00015568413,0.0003271979,0.0002967004,0.00033748697,0.0016230951],"category_scores_gemma":[0.00012430605,0.00013243136,0.00025161056,0.000106434054,0.0002176081,0.00028817973,0.00020649866,0.00067978684,0.0002743644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011159373,0.00011277001,0.00025489304,0.00012778041,0.000061553365,0.00009893117,0.000016804019,0.000087831904,0.9897497,0.00015730095,0.00022567998,0.007990744],"study_design_scores_gemma":[0.00021940716,0.0020177066,0.0063445894,0.00002195031,0.00008872302,0.00026223535,0.000039128907,0.00077565433,0.98697376,0.00009971118,0.0031451683,0.000011889544],"about_ca_topic_score_codex":0.00046846378,"about_ca_topic_score_gemma":0.0011121792,"teacher_disagreement_score":0.0016230951,"about_ca_system_score_codex":0.00021892128,"about_ca_system_score_gemma":0.00029100085,"threshold_uncertainty_score":0.0054298043},"labels":[],"label_agreement":null},{"id":"W3087534195","doi":"10.1007/s10557-020-07077-8","title":"Efficacy of Sodium Tanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Controlled, Randomized Trial","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Traditional Chinese Medicine Analysis","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Acute coronary syndrome; Internal medicine; Myocardial infarction; Cardiology; Mace; Clinical endpoint; Randomized controlled trial; Odds ratio; ST elevation; Revascularization","score_opus":0.009104132250471887,"score_gpt":0.21931784398575102,"score_spread":0.21021371173527914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087534195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362224,0.0043633175,0.00026334854,0.00022739594,0.00017418165,0.0004986066,0.00029246928,0.000019391371,0.0005391063],"genre_scores_gemma":[0.99554753,0.0020550159,0.0004645975,0.0003538325,0.00020391181,0.00036852204,0.00047836837,0.000005255948,0.0005228851],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988925,0.0006619749,0.00011335352,0.00014609436,0.00008358308,0.00010252666],"domain_scores_gemma":[0.998723,0.0004668154,0.0003388348,0.00010893162,0.0001035568,0.00025888326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018363993,0.0012222998,0.0034551388,0.00036260614,0.00042036336,0.00084327086,0.0005613019,0.0012474421,0.0027397652],"category_scores_gemma":[0.002094854,0.0005981817,0.0030479608,0.0006181225,0.00082505826,0.00070457713,0.00038908108,0.0014472193,0.00027757697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9794882,0.0017069342,0.004758406,0.00062500476,0.005089871,0.000030217248,0.000043214874,0.00015159225,0.001475902,0.000041998366,0.00016631077,0.0064223926],"study_design_scores_gemma":[0.9323078,0.035716347,0.02275798,0.000063277104,0.007813038,0.000032500335,0.00006999817,0.00047029046,0.00034695765,0.00010442117,0.00028984642,0.000027579572],"about_ca_topic_score_codex":0.0014737564,"about_ca_topic_score_gemma":0.0033360142,"teacher_disagreement_score":0.0034551388,"about_ca_system_score_codex":0.00056889164,"about_ca_system_score_gemma":0.001064387,"threshold_uncertainty_score":0.009711921},"labels":[],"label_agreement":null},{"id":"W3118645080","doi":"10.1007/s10557-020-07124-4","title":"Ivabradine in Cardiovascular Disease Management Revisited: a Review","year":2021,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Ivabradine; Medicine; Heart failure; Cardiology; Internal medicine; Sinoatrial node; Heart rate; Ejection fraction; Management of heart failure; Tachycardia; Contractility; Anesthesia; Blood pressure","score_opus":0.0368834976657494,"score_gpt":0.3190213885286442,"score_spread":0.2821378908628948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118645080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003718937,0.9996131,0.000021915881,0.0001417349,0.00008036137,0.0000021857343,0.0000086395785,0.0000018857901,0.000093040355],"genre_scores_gemma":[0.00033064422,0.9990827,0.00009071911,0.00029081712,0.00011405898,0.0000039917472,0.000010725856,5.9765614e-7,0.00007567478],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971026,0.00006381825,0.000081112776,0.00005410495,0.00006823037,0.000022348897],"domain_scores_gemma":[0.9991904,0.00046664922,0.00015365875,0.000012350978,0.00012485901,0.000052118958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011250902,0.0008522641,0.0030925851,0.0023339887,0.00023672597,0.0017009362,0.001151705,0.0014348966,0.0036811607],"category_scores_gemma":[0.0015246883,0.00038490878,0.0010492337,0.0025743933,0.00043590512,0.0017534805,0.0008870993,0.0028047333,0.00087130506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035472185,0.00012224817,0.00023772486,0.07415589,0.0005934904,0.00018552155,0.00007934261,0.0002688753,0.0008267997,0.0019612734,0.028468624,0.8927455],"study_design_scores_gemma":[0.0005293378,0.00059263804,0.0028021324,0.060177103,0.003723314,0.0015559497,0.00019745117,0.00031549268,0.00039578305,0.0023411363,0.92730105,0.00006860453],"about_ca_topic_score_codex":0.0013725916,"about_ca_topic_score_gemma":0.0041729603,"teacher_disagreement_score":0.0036811607,"about_ca_system_score_codex":0.0006389792,"about_ca_system_score_gemma":0.0014659209,"threshold_uncertainty_score":0.012314677},"labels":[],"label_agreement":null},{"id":"W31420755","doi":"10.1007/s10557-019-06900-1","title":"New Rotaxane Ligands for Metal Complexes and Frameworks","year":2012,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Supramolecular Chemistry and Complexes","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Rotaxane; Chemistry; Crystallography; Supramolecular chemistry; Crystal structure","score_opus":0.014047655621156648,"score_gpt":0.23157502178360984,"score_spread":0.2175273661624532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31420755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83698344,0.014465161,0.06887143,0.002503141,0.00088712364,0.0004958678,0.0009896768,0.0018780892,0.07292615],"genre_scores_gemma":[0.9701039,0.0032736196,0.01703787,0.0005553547,0.000098723925,0.00023672161,0.0003882345,0.00009784287,0.00820763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998622,0.000028743456,0.000006984753,0.000034472778,0.000022413837,0.000045158387],"domain_scores_gemma":[0.9999291,0.000019866502,0.000017760725,0.000011258118,0.00000899025,0.000013098287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018207732,0.00045779374,0.00022507636,0.0002379155,0.00032752342,0.00032287423,0.0008770035,0.00039820775,0.007887054],"category_scores_gemma":[0.00025671037,0.0001322852,0.0001468561,0.00020133638,0.00023307074,0.00049594213,0.0005703584,0.00067150465,0.00078495726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013139741,0.00022746727,0.00026554236,0.0021000952,0.00006478386,0.0006613167,0.00031917394,0.0038540594,0.8921036,0.04781738,0.008059099,0.043213557],"study_design_scores_gemma":[0.00031405233,0.0022438883,0.0006865447,0.00015285937,0.00006569035,0.0010790634,0.00018505196,0.0069449637,0.87125576,0.005297595,0.1116469,0.00012773706],"about_ca_topic_score_codex":0.00028722873,"about_ca_topic_score_gemma":0.00043338374,"teacher_disagreement_score":0.007887054,"about_ca_system_score_codex":0.00035887258,"about_ca_system_score_gemma":0.0001491529,"threshold_uncertainty_score":0.02638489},"labels":[],"label_agreement":null},{"id":"W3153821777","doi":"10.1007/s10557-021-07190-2","title":"Empagliflozin Disrupts a Tnfrsf12a-Mediated Feed Forward Loop That Promotes Left Ventricular Hypertrophy","year":2021,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; St. Michael's Hospital","funders":"University of Toronto; Diabetes Canada; Heart and Stroke Foundation of Canada","keywords":"Empagliflozin; Medicine; Internal medicine; Muscle hypertrophy; Endocrinology; Downregulation and upregulation; Heart failure; Ventricular remodeling; Cardiology; Diabetes mellitus; Type 2 Diabetes Mellitus; Biology","score_opus":0.012318528423553075,"score_gpt":0.22061887340640396,"score_spread":0.20830034498285088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153821777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97908795,0.004406797,0.008920372,0.0024544373,0.0008603127,0.000081442005,0.000912668,0.0005095522,0.0027665286],"genre_scores_gemma":[0.98911357,0.0018102333,0.0049505383,0.0006060649,0.0001590336,0.00009246671,0.0005002757,0.00004624224,0.0027214617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975854,0.00004744273,0.000022190583,0.000043661046,0.00006367444,0.00006449639],"domain_scores_gemma":[0.9998349,0.000031854033,0.000054542077,0.00001643536,0.0000199458,0.000042293977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038478203,0.00039837896,0.000492822,0.0003209925,0.00018616718,0.00047062067,0.00028068264,0.00049528165,0.0019607076],"category_scores_gemma":[0.00035981965,0.00024653965,0.0003987867,0.00014310546,0.00036142534,0.00030550937,0.00024801577,0.0018594771,0.00048635763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011164192,0.0010328937,0.0029340815,0.0003973774,0.00024855838,0.00037266107,0.000066435605,0.0014575272,0.9130639,0.0010128042,0.004050834,0.06419872],"study_design_scores_gemma":[0.0054985383,0.009135605,0.05181682,0.00016493743,0.00072777865,0.001841373,0.0003547896,0.018606339,0.8734753,0.0015126605,0.036768075,0.000097857235],"about_ca_topic_score_codex":0.00093876076,"about_ca_topic_score_gemma":0.001428056,"teacher_disagreement_score":0.0019607076,"about_ca_system_score_codex":0.00037697246,"about_ca_system_score_gemma":0.00038678266,"threshold_uncertainty_score":0.006559193},"labels":[],"label_agreement":null},{"id":"W3182880598","doi":"10.1007/s10557-021-07213-y","title":"Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries","year":2021,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Clopidogrel; Percutaneous coronary intervention; Acute coronary syndrome; Hazard ratio; Internal medicine; Conventional PCI; Propensity score matching; Cardiology; Population; Proportional hazards model; Incidence (geometry); Confidence interval; Myocardial infarction","score_opus":0.01622971902274478,"score_gpt":0.2506818035223317,"score_spread":0.23445208449958693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182880598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991054,0.00018314319,0.00018064409,0.000021133666,0.000007866181,0.000015181473,0.0003692551,0.0000020310358,0.00011528136],"genre_scores_gemma":[0.9988042,0.000088536566,0.00012735948,0.000040534993,0.000015968599,0.000018113786,0.0008142386,0.0000035927346,0.00008749565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973394,0.000983209,0.00038646042,0.000759799,0.00025473145,0.00027619847],"domain_scores_gemma":[0.99589217,0.0007658187,0.0021595985,0.0006916995,0.00020432583,0.0002863327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023740872,0.00053042814,0.0009835656,0.0011197083,0.0007331878,0.0011976395,0.0007399296,0.0008508985,0.001323611],"category_scores_gemma":[0.0050107166,0.00068647193,0.0019004107,0.0031222086,0.00048178175,0.00067060225,0.0009986612,0.0007998477,0.00020321972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011026586,0.00007025517,0.99627703,0.000015995189,0.0010553477,0.00011196304,0.00007418388,0.000117528885,0.00019814823,0.000035740584,0.00016178016,0.0007793028],"study_design_scores_gemma":[0.00018461273,0.00018499729,0.9970734,0.00001042598,0.00087780907,0.00020807641,0.00020608005,0.0008617979,0.00007327549,0.000058037975,0.00024983153,0.000011601818],"about_ca_topic_score_codex":0.008608753,"about_ca_topic_score_gemma":0.009776524,"teacher_disagreement_score":0.008608753,"about_ca_system_score_codex":0.00048186717,"about_ca_system_score_gemma":0.00062283006,"threshold_uncertainty_score":0.017117321},"labels":[],"label_agreement":null},{"id":"W3195088871","doi":"10.1007/s10557-021-07198-8","title":"Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding","year":2021,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Medicine; Angina; Conventional PCI; Placebo; Blinding; Percutaneous coronary intervention; Revascularization; Myocardial infarction; Quality of life (healthcare); Canadian Cardiovascular Society; Physical therapy; Internal medicine; Randomized controlled trial; Clinical endpoint; Clinical trial; Coronary artery disease; Cardiology","score_opus":0.04682880072613276,"score_gpt":0.34122477045394095,"score_spread":0.2943959697278082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195088871","genre_codex":"review","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025479611,0.8683843,0.028355533,0.06480825,0.0029315737,0.0020809313,0.00093966466,0.000070821996,0.0069492497],"genre_scores_gemma":[0.5488559,0.2756914,0.09386256,0.049874682,0.011402454,0.01738645,0.0011841161,0.00032302746,0.0014194514],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.4362369,0.51866174,0.017105332,0.0064032334,0.019892015,0.001700798],"domain_scores_gemma":[0.3294959,0.6087083,0.033736095,0.016561197,0.00958123,0.001917244],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.41336387,0.0015262484,0.009561698,0.0044300347,0.0012993037,0.006840473,0.002169704,0.005326114,0.0022778346],"category_scores_gemma":[0.45564595,0.0011063431,0.006396192,0.006080669,0.010518336,0.006011956,0.00759357,0.008292374,0.00030193708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031031834,0.0006102613,0.021147668,0.03555513,0.025748383,0.00015977399,0.0052335165,0.0060642995,0.0006788766,0.10544184,0.012956957,0.7553714],"study_design_scores_gemma":[0.057945456,0.013091842,0.09882368,0.09098876,0.017477203,0.00093517633,0.001972428,0.016658206,0.0011459326,0.6006701,0.09911541,0.0011758691],"about_ca_topic_score_codex":0.0035198862,"about_ca_topic_score_gemma":0.0031000136,"teacher_disagreement_score":0.41336387,"about_ca_system_score_codex":0.007916949,"about_ca_system_score_gemma":0.0077104634,"threshold_uncertainty_score":0.7234268},"labels":[],"label_agreement":null},{"id":"W3199816962","doi":"10.1007/s10557-021-07248-1","title":"The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases","year":2021,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of Toronto","funders":"Servier","keywords":"Medicine; Bisoprolol; Perindopril; Heart failure; Ramipril; Cardiology; Eplerenone; Context (archaeology); Internal medicine; Blood pressure; Intensive care medicine; Spironolactone","score_opus":0.02593851143375832,"score_gpt":0.2862968409751293,"score_spread":0.260358329541371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199816962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12761918,0.8441138,0.0026274235,0.004891334,0.0017577553,0.00039216186,0.00040006745,0.00007659737,0.018121742],"genre_scores_gemma":[0.54503435,0.43667412,0.008379989,0.0034331765,0.0026282668,0.00031173986,0.00040203254,0.000022404518,0.0031138747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783033,0.0010827754,0.00030734978,0.00017277434,0.0005171683,0.00008948706],"domain_scores_gemma":[0.999054,0.00031266426,0.00034506083,0.000046077308,0.000113641276,0.00012858874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016758348,0.00037280773,0.0014984966,0.00067057414,0.0002454336,0.0009717992,0.00035245004,0.00043541632,0.0021564],"category_scores_gemma":[0.0020168666,0.00016121895,0.00095975195,0.00094086624,0.00020308839,0.0005806509,0.0004500613,0.0010684544,0.0005328816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02304703,0.0024365175,0.023100276,0.0121838795,0.007670855,0.00052134733,0.000115213974,0.00063459,0.01191637,0.0025008372,0.010353645,0.90551937],"study_design_scores_gemma":[0.032756392,0.11426371,0.2683249,0.0151666785,0.03978183,0.011643888,0.0008939167,0.0033978876,0.016854694,0.009417202,0.48727536,0.00022350006],"about_ca_topic_score_codex":0.00029097393,"about_ca_topic_score_gemma":0.0012540707,"teacher_disagreement_score":0.0021564,"about_ca_system_score_codex":0.000268,"about_ca_system_score_gemma":0.00046578213,"threshold_uncertainty_score":0.008862734},"labels":[],"label_agreement":null},{"id":"W3203892369","doi":"10.1007/s10557-021-07268-x","title":"The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD","year":2021,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Medicine; Ezetimibe; Atherosclerotic cardiovascular disease; Population; Cumulative incidence; Internal medicine; PCSK9; Incidence (geometry); Evolocumab; Statin; Familial hypercholesterolemia; Cholesterol; Endocrinology; Lipoprotein; Cohort; Disease; LDL receptor; Environmental health","score_opus":0.009495244920186595,"score_gpt":0.25865906467720745,"score_spread":0.24916381975702084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203892369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91742927,0.007822585,0.010199886,0.017844383,0.00061507896,0.000088269866,0.030883642,0.00040066842,0.014716346],"genre_scores_gemma":[0.9897188,0.0019088117,0.0011159487,0.0008529089,0.00017254728,0.000043621043,0.00489719,0.000012918431,0.0012773299],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986608,0.00059171364,0.0000795797,0.0001931193,0.00015682544,0.00031807998],"domain_scores_gemma":[0.99737984,0.00055317505,0.0006066659,0.00016871915,0.0006176533,0.00067392015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030675246,0.0007200941,0.000647368,0.0005587331,0.00041354133,0.0011581718,0.00092257344,0.0019133794,0.0043844157],"category_scores_gemma":[0.005944283,0.00049894897,0.002735676,0.0006595992,0.00037832724,0.0014040064,0.0011850242,0.0017695786,0.0009105825],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026786886,0.00060770585,0.8692679,0.00043994802,0.0027208175,0.0012153491,0.00021337548,0.050397694,0.0024818562,0.0083667245,0.017127868,0.044482127],"study_design_scores_gemma":[0.00017537727,0.001293413,0.9166597,0.0002241142,0.002797386,0.0013919823,0.000867901,0.062897116,0.0013389832,0.005751537,0.006487057,0.00011537391],"about_ca_topic_score_codex":0.028568324,"about_ca_topic_score_gemma":0.025631577,"teacher_disagreement_score":0.028568324,"about_ca_system_score_codex":0.0013920087,"about_ca_system_score_gemma":0.0018016523,"threshold_uncertainty_score":0.05680406},"labels":[],"label_agreement":null},{"id":"W3214476949","doi":"10.1007/s10557-021-07291-y","title":"The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus","year":2021,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Stroke (engine); Myocardial infarction; Diabetes mellitus; Type 2 Diabetes Mellitus; Glycemic; Internal medicine; Incidence (geometry); Heart failure; Cardiology; Clinical trial; Type 2 diabetes; Intensive care medicine; Endocrinology","score_opus":0.0072821266201930305,"score_gpt":0.22312815584430523,"score_spread":0.2158460292241122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214476949","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79225826,0.19490813,0.0018519061,0.0027556608,0.0006573907,0.00013266283,0.00044636507,0.00016032865,0.0068291705],"genre_scores_gemma":[0.9632458,0.030558892,0.0027247593,0.001138567,0.000977942,0.0000900258,0.00037365672,0.000020808893,0.0008695002],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995864,0.00018281837,0.000056337347,0.000049315768,0.00008341809,0.000041714957],"domain_scores_gemma":[0.9994535,0.00017727706,0.00012712047,0.000030103876,0.000067309054,0.00014471845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010696597,0.0007414105,0.0017952396,0.00045306908,0.00018765082,0.0006969828,0.0002720734,0.0004774805,0.001716489],"category_scores_gemma":[0.0013538483,0.00019397977,0.0013691358,0.00052500755,0.0001696796,0.00045516508,0.00038829498,0.0010810533,0.00023918327],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13604344,0.005368449,0.109970465,0.0044093146,0.015526895,0.00040497334,0.00012288056,0.002085676,0.018046372,0.00031308853,0.003620801,0.7040877],"study_design_scores_gemma":[0.03369106,0.10658382,0.7874137,0.0016567236,0.02533583,0.0022851569,0.00033455103,0.009969702,0.012448966,0.0015810587,0.018571038,0.00012836453],"about_ca_topic_score_codex":0.0004555245,"about_ca_topic_score_gemma":0.0015731765,"teacher_disagreement_score":0.0017952396,"about_ca_system_score_codex":0.00026504602,"about_ca_system_score_gemma":0.00041492796,"threshold_uncertainty_score":0.005742252},"labels":[],"label_agreement":null},{"id":"W374002311","doi":"10.1023/a:1012702928239","title":"Angiotensin Converting Enzyme Inhibitors and Restenosis: Let's Stop Teasing Ourselves","year":2001,"lang":"en","type":"letter","venue":"Cardiovascular Drugs and Therapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Restenosis; Angiotensin-converting enzyme; Enzyme; Internal medicine; Angiotensin II; Renin–angiotensin system; Endocrinology; Pharmacology; Biochemistry; Receptor; Stent","score_opus":0.02497871304109343,"score_gpt":0.23611824693177502,"score_spread":0.2111395338906816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W374002311","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070750486,0.012280876,0.000058020596,0.9718032,0.013353222,0.000005017078,0.000020155832,0.000013715843,0.0017583364],"genre_scores_gemma":[0.0062555163,0.009128188,0.00018933607,0.8932455,0.08573296,0.000020019885,0.000022294766,0.00001277924,0.005393408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793965,0.00079080835,0.00029321059,0.0002253823,0.0005258148,0.00022504618],"domain_scores_gemma":[0.9919944,0.004762092,0.000665727,0.00024142096,0.00083881343,0.0014975059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002977469,0.0008433697,0.0022295339,0.0007836419,0.0030559392,0.003003773,0.0014720773,0.038229063,0.0058314926],"category_scores_gemma":[0.018309195,0.00058752816,0.0009577852,0.00085787947,0.002293867,0.0052445056,0.0012992431,0.03000736,0.004053689],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026974574,0.00012195637,0.0025208145,0.00020072125,0.00007151751,0.0029478855,0.00019871583,0.000034202316,0.0002369621,0.0022409817,0.96051216,0.030644456],"study_design_scores_gemma":[0.0011302029,0.0004031023,0.009234803,0.0017073335,0.0003144464,0.01199963,0.0018455413,0.00039705003,0.00026956727,0.01654734,0.95598865,0.00016237736],"about_ca_topic_score_codex":0.003363833,"about_ca_topic_score_gemma":0.00888348,"teacher_disagreement_score":0.038229063,"about_ca_system_score_codex":0.0017282927,"about_ca_system_score_gemma":0.0024467027,"threshold_uncertainty_score":0.019508243},"labels":[],"label_agreement":null},{"id":"W4200498388","doi":"10.1007/s10557-021-07308-6","title":"Correction to: The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus","year":2021,"lang":"en","type":"erratum","venue":"Cardiovascular Drugs and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Myocardial infarction; Stroke (engine); Diabetes mellitus; Incidence (geometry); Type 2 Diabetes Mellitus; Internal medicine; Type 2 diabetes; Ischemic stroke; Cardiology; Intensive care medicine; Endocrinology; Ischemia","score_opus":0.0036856243073711365,"score_gpt":0.19047279683273033,"score_spread":0.1867871725253592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200498388","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035467736,0.0012911415,0.00016365448,0.02298605,0.97423404,0.000013652583,0.00035867895,0.000064248045,0.0008530347],"genre_scores_gemma":[0.0036182795,0.011702829,0.0023529935,0.065783635,0.821893,0.00014361527,0.0011642815,0.00053007447,0.09281121],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966254,0.00071629364,0.00070611655,0.0004851254,0.001150161,0.0003169882],"domain_scores_gemma":[0.9755525,0.006167683,0.001229766,0.0009595887,0.014402206,0.0016882087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004094664,0.0031910054,0.0032086812,0.003670625,0.002070076,0.004100572,0.0035473292,0.007197494,0.045545034],"category_scores_gemma":[0.0408879,0.0013259869,0.002469909,0.0022978561,0.0019048132,0.0020759967,0.0013258866,0.013714921,0.025937468],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005549689,0.0000081630205,0.000046536006,0.00018657678,0.000019469187,0.00015513941,0.000010825875,0.000034942885,0.000022467293,0.00022987757,0.99407566,0.005154865],"study_design_scores_gemma":[0.00018576773,0.00003845177,0.0009162689,0.0006556765,0.00009627398,0.0006696934,0.000054001302,0.00027841807,0.00022180074,0.0007726733,0.99606675,0.00004422295],"about_ca_topic_score_codex":0.019368928,"about_ca_topic_score_gemma":0.023449523,"teacher_disagreement_score":0.045545034,"about_ca_system_score_codex":0.003637761,"about_ca_system_score_gemma":0.0057505327,"threshold_uncertainty_score":0.15236336},"labels":[],"label_agreement":null},{"id":"W4206381116","doi":"10.1007/s10557-021-07309-5","title":"Response to the Letter on “The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus”","year":2022,"lang":"en","type":"letter","venue":"Cardiovascular Drugs and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Stroke (engine); Incidence (geometry); Myocardial infarction; Diabetes mellitus; Type 2 Diabetes Mellitus; Internal medicine; Type 2 diabetes; Cardiology; Ischemic stroke; Infarction; Endocrinology; Ischemia","score_opus":0.005263621629368385,"score_gpt":0.18851234008850912,"score_spread":0.18324871845914073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206381116","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002722278,0.0008654525,0.00006042855,0.9666703,0.029513491,0.000021181972,0.00016644187,0.00003207139,0.0023984208],"genre_scores_gemma":[0.0011236715,0.00051705627,0.00009759495,0.96916413,0.0228021,0.00003762671,0.00005726914,0.0000169368,0.0061835074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681324,0.0008899346,0.00039332727,0.00038988993,0.00097221177,0.00054130726],"domain_scores_gemma":[0.99360436,0.0030733522,0.0005794633,0.00013232543,0.0014819866,0.0011285719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003611654,0.0011444706,0.0020614248,0.00084369484,0.003323742,0.003667559,0.0017837493,0.052129213,0.00907026],"category_scores_gemma":[0.018315753,0.00087011664,0.0019268659,0.00070581405,0.001673644,0.0021251352,0.0012510737,0.03270417,0.010414205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091002854,0.000036314337,0.0003321709,0.000038819886,0.000016315415,0.00046550334,0.00003409091,0.000027274156,0.000080022655,0.00037265153,0.99539125,0.0031145941],"study_design_scores_gemma":[0.00037671695,0.00018295972,0.0030804588,0.00051862246,0.00008446118,0.0009705063,0.00033949304,0.00047408327,0.00028480677,0.0024704111,0.99111676,0.000100864534],"about_ca_topic_score_codex":0.012572996,"about_ca_topic_score_gemma":0.020089973,"teacher_disagreement_score":0.052129213,"about_ca_system_score_codex":0.004639331,"about_ca_system_score_gemma":0.0061671445,"threshold_uncertainty_score":0.03366083},"labels":[],"label_agreement":null},{"id":"W4211137063","doi":"10.1007/s10557-022-07320-4","title":"Branched-Chain Amino Acid Metabolism in the Failing Heart","year":2022,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Heart failure; Internal medicine; Medicine; Branched-chain amino acid; Insulin resistance; Endocrinology; Metabolism; Amino acid; PI3K/AKT/mTOR pathway; Cardiac function curve; Heart disease; Beta oxidation; Cardiology; Insulin; Biochemistry; Signal transduction; Chemistry","score_opus":0.03949888448682623,"score_gpt":0.2873036141671605,"score_spread":0.24780472968033426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211137063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050018698,0.99949455,0.0000334744,0.00010624566,0.00009391423,0.0000011710831,0.000008725476,0.0000019724362,0.00020995513],"genre_scores_gemma":[0.00027415337,0.9992539,0.000067670626,0.00009583719,0.0001443527,0.0000017997684,0.000013246744,4.661871e-7,0.00014860749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998939,0.000021016554,0.00002025534,0.000020175527,0.000033488857,0.000011081761],"domain_scores_gemma":[0.99969816,0.00015635662,0.00005918136,0.0000061514556,0.000052520958,0.000027562917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004637365,0.0008672762,0.001760044,0.001501504,0.0001693137,0.00090805045,0.00068339787,0.00088755245,0.0033201643],"category_scores_gemma":[0.0006237773,0.00022944609,0.0004687336,0.0017074057,0.00030738415,0.00079913804,0.00068204966,0.0016432146,0.0012754295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016955595,0.000075673415,0.00020645319,0.019911665,0.00020636343,0.00012487744,0.000018939709,0.0003145517,0.00084551965,0.0012738561,0.019708784,0.9571438],"study_design_scores_gemma":[0.00015986683,0.00031843962,0.0030008194,0.01754162,0.0010508997,0.0016659921,0.00007710959,0.00032441906,0.00063330244,0.0035211865,0.97165674,0.000049642746],"about_ca_topic_score_codex":0.0013830739,"about_ca_topic_score_gemma":0.002942204,"teacher_disagreement_score":0.0033201643,"about_ca_system_score_codex":0.00044849384,"about_ca_system_score_gemma":0.00089169876,"threshold_uncertainty_score":0.0111070275},"labels":[],"label_agreement":null},{"id":"W4224270466","doi":"10.1007/s10557-022-07328-w","title":"A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients","year":2022,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Apelin-related biomedical research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Amgen","keywords":"Medicine; Agonist; Apelin; Heart failure; Receptor; Internal medicine; Endocrinology; Pharmacology; Human heart; Cardiology","score_opus":0.01719826069039664,"score_gpt":0.28099727494272875,"score_spread":0.2637990142523321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224270466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954751,0.00087614614,0.00060297904,0.00006585174,0.00006998058,0.00037385125,0.00046469687,0.000021403246,0.0020499537],"genre_scores_gemma":[0.9932974,0.00045656387,0.00057074596,0.00046769332,0.00013275836,0.0003620862,0.0009470342,0.000017383143,0.0037484074],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99960166,0.000129661,0.000023152354,0.000118365795,0.000037643684,0.000089583016],"domain_scores_gemma":[0.9990527,0.0002569299,0.0000814593,0.00017158578,0.00008613636,0.00035121266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010560272,0.00082253764,0.0011702474,0.00036639266,0.0013569832,0.0008084791,0.00034029695,0.0014404593,0.005377261],"category_scores_gemma":[0.0011151619,0.00067285285,0.00074424455,0.00023945708,0.0008998329,0.0008299758,0.0004672982,0.0015531338,0.0010555449],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4414799,0.06538008,0.26703015,0.0009957525,0.0024307547,0.0047910437,0.0029696324,0.0004371934,0.14598916,0.0007114744,0.0028465423,0.0649383],"study_design_scores_gemma":[0.012768418,0.21795543,0.7449479,0.00004814347,0.0017217417,0.0028407495,0.0014418374,0.0008198948,0.009299658,0.00046719,0.0075368695,0.00015222738],"about_ca_topic_score_codex":0.0028973345,"about_ca_topic_score_gemma":0.0023624338,"teacher_disagreement_score":0.005377261,"about_ca_system_score_codex":0.0003688619,"about_ca_system_score_gemma":0.0004880276,"threshold_uncertainty_score":0.017988741},"labels":[],"label_agreement":null},{"id":"W4285793383","doi":"10.1007/s10557-021-07185-z","title":"Evolving Roles of Optimal Medical Therapy and PCI in Chronic Coronary Syndrome Patients with Stable Angina: Introduction","year":2022,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Angina; Clinical trial; Revascularization; Conventional PCI; Canadian Cardiovascular Society; Fractional flow reserve; Internal medicine; Acute coronary syndrome; Randomized controlled trial; Intensive care medicine; Unstable angina; Medical therapy; Cardiology; Coronary heart disease; Myocardial infarction","score_opus":0.017060258745153718,"score_gpt":0.25989433517281996,"score_spread":0.24283407642766625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285793383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004022239,0.9991911,0.000041601656,0.00045273761,0.00012850328,0.0000017420182,0.0000066773864,0.0000013775361,0.00013599885],"genre_scores_gemma":[0.00068170094,0.997581,0.00020595973,0.0007401399,0.00071001105,0.0000063074367,0.000015058833,0.0000010171,0.000058822756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911267,0.00027634963,0.00022501372,0.00014924373,0.00018832507,0.00004841161],"domain_scores_gemma":[0.9963887,0.0025396242,0.0005515044,0.00004581322,0.0003862885,0.00008816138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026841813,0.0010403359,0.003364978,0.0022805235,0.00027016163,0.0022824467,0.0012422339,0.0018961646,0.0032060228],"category_scores_gemma":[0.0057925303,0.0005145812,0.0014524445,0.0021103013,0.00088640646,0.0029229787,0.0012167686,0.0035082595,0.0006175334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032506272,0.000095874624,0.00064016954,0.05484834,0.00056649034,0.00009953785,0.0001006097,0.00039418886,0.0002521909,0.005667219,0.02432836,0.912682],"study_design_scores_gemma":[0.0005198646,0.0005959146,0.008092478,0.13412288,0.004046442,0.0012730872,0.00034465364,0.0007993611,0.00026149832,0.00903018,0.84077483,0.00013877003],"about_ca_topic_score_codex":0.0020795204,"about_ca_topic_score_gemma":0.005136767,"teacher_disagreement_score":0.003364978,"about_ca_system_score_codex":0.001400259,"about_ca_system_score_gemma":0.0027441697,"threshold_uncertainty_score":0.014195442},"labels":[],"label_agreement":null},{"id":"W4296330756","doi":"10.1007/s10557-022-07381-5","title":"Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study","year":2022,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Institute for Clinical Evaluative Sciences; University of Manitoba","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Atrial fibrillation; Warfarin; Hazard ratio; Retrospective cohort study; Thrombosis; Internal medicine; Cohort; Valve replacement; Cardiology; Cohort study; Surgery; Population; Confidence interval; Stenosis","score_opus":0.024286585605417167,"score_gpt":0.28200931271963675,"score_spread":0.25772272711421956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296330756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986614,0.00048220725,0.00009399671,0.00003936295,0.000018367726,0.000013586462,0.0005029876,0.0000024044734,0.00018575123],"genre_scores_gemma":[0.9987954,0.00024349839,0.000105685525,0.000061005707,0.000028722154,0.000017370352,0.0006202929,0.000003882445,0.00012416001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986014,0.0003219975,0.000197903,0.00051727827,0.00015174663,0.00020976632],"domain_scores_gemma":[0.99748874,0.00046171152,0.0011461731,0.0003552277,0.0001958361,0.00035225498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001087735,0.00053829956,0.0009788153,0.00064480404,0.00080152665,0.0016232298,0.0007234001,0.0011473644,0.0016145686],"category_scores_gemma":[0.0035975282,0.00082581287,0.0016963126,0.0015017356,0.00057801435,0.0012966612,0.00076627487,0.0014933761,0.0003097795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014541749,0.00014155374,0.9963276,0.000028300436,0.00080636516,0.00015632839,0.00011057848,0.000036246827,0.00018677844,0.00003592211,0.0001460984,0.00057016464],"study_design_scores_gemma":[0.00032395008,0.00071038445,0.9954715,0.000024833602,0.000709164,0.0010429694,0.0007958406,0.00040158778,0.00007889333,0.00009326035,0.0003191139,0.0000285724],"about_ca_topic_score_codex":0.005990588,"about_ca_topic_score_gemma":0.007965472,"teacher_disagreement_score":0.005990588,"about_ca_system_score_codex":0.00055244734,"about_ca_system_score_gemma":0.0005824516,"threshold_uncertainty_score":0.011911452},"labels":[],"label_agreement":null},{"id":"W4297964575","doi":"10.1007/s10557-022-07377-1","title":"The SGLT2i Dapagliflozin Reduces RV Mass Independent of Changes in RV Pressure Induced by Pulmonary Artery Banding","year":2022,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; Hospital for Sick Children; St. Michael's Hospital","funders":"Canada Excellence Research Chairs, Government of Canada","keywords":"Medicine; Heart failure; Internal medicine; Cardiology; Dapagliflozin; Afterload; Pulmonary artery; Pulmonary artery banding; Ventricle; Pressure overload; Endocrinology; Diabetes mellitus","score_opus":0.013491550351550809,"score_gpt":0.22377223627140191,"score_spread":0.2102806859198511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297964575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921225,0.0028184822,0.0024195754,0.00056553475,0.00026475798,0.00003384968,0.00016875072,0.0001835169,0.0014230367],"genre_scores_gemma":[0.9953968,0.0012687627,0.0016422501,0.00030654468,0.0002921629,0.000040430856,0.00022043228,0.000018702303,0.0008138963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991596,0.000018352779,0.000007810776,0.000013001194,0.000021101932,0.00002369246],"domain_scores_gemma":[0.99984145,0.00003445306,0.000046818015,0.00001583914,0.0000079276815,0.000053415664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022024573,0.00029669108,0.00069875724,0.00014795199,0.000088454115,0.00033361002,0.00017435537,0.00022718345,0.0007034853],"category_scores_gemma":[0.00038897202,0.00013174416,0.0003096177,0.00009985373,0.00022614114,0.00032021187,0.00020908416,0.0012742401,0.00014082104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09594911,0.0056563215,0.013245451,0.0009384331,0.00068692403,0.0003821414,0.00007625003,0.0016957414,0.5382885,0.00073563337,0.0047887363,0.33755672],"study_design_scores_gemma":[0.03764079,0.15002328,0.4428702,0.00025983396,0.0023859174,0.0021081585,0.00025279718,0.02581513,0.31391674,0.0012928486,0.023318734,0.0001155725],"about_ca_topic_score_codex":0.00030401387,"about_ca_topic_score_gemma":0.0004913552,"teacher_disagreement_score":0.0007034853,"about_ca_system_score_codex":0.00018636415,"about_ca_system_score_gemma":0.00020867806,"threshold_uncertainty_score":0.0023533702},"labels":[],"label_agreement":null},{"id":"W4310290800","doi":"10.1007/s10557-022-07392-2","title":"Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study","year":2022,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Toronto General Hospital; St. Michael's Hospital","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Regeneron Pharmaceuticals; Bayer Canada; Esperion Therapeutics; Servier; Novo Nordisk; Daiichi-Sankyo; Boston Scientific Corporation; Pfizer; York University; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Eli Lilly Canada; AstraZeneca Canada; University of Toronto; Heart and Stroke Foundation of Canada; American Regent; Sanofi; Amgen; HLS Therapeutics; U.S. Department of Health and Human Services","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Kidney disease; Internal medicine; Clinical endpoint; Renal function; Myocardial infarction; Post-hoc analysis; Cardiology; Randomized controlled trial; Population; P2Y12","score_opus":0.008144742595637439,"score_gpt":0.23868037082058552,"score_spread":0.23053562822494808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310290800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973152,0.0006718328,0.00043751756,0.00009417801,0.000059387643,0.00015812814,0.00054372294,0.000052507818,0.00066739554],"genre_scores_gemma":[0.99738544,0.00024404976,0.0005059711,0.00015004043,0.0001433874,0.00018574066,0.0006365196,0.000027415412,0.00072148786],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971642,0.0016262894,0.00013075749,0.0004996032,0.00021170807,0.0003674042],"domain_scores_gemma":[0.99687046,0.0013377455,0.00064971315,0.00069049903,0.00014940082,0.00030228074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036494546,0.0015580085,0.0048134127,0.00033326066,0.00030606767,0.0013247418,0.0007994971,0.0010281134,0.002450882],"category_scores_gemma":[0.0040217256,0.00046664273,0.0034800277,0.0005717493,0.00085881713,0.001339366,0.0005945267,0.002500041,0.0003945322],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9586461,0.0023655263,0.012196374,0.00019257223,0.006191532,0.00006246434,0.00007702525,0.001338518,0.002504865,0.00011368785,0.00071673316,0.015594528],"study_design_scores_gemma":[0.40268353,0.27696607,0.28396338,0.00008041439,0.018317515,0.00018842658,0.00019646244,0.009482244,0.0046788943,0.0013607244,0.0018404097,0.00024188121],"about_ca_topic_score_codex":0.00076040643,"about_ca_topic_score_gemma":0.0013776047,"teacher_disagreement_score":0.0048134127,"about_ca_system_score_codex":0.0006291293,"about_ca_system_score_gemma":0.00081171084,"threshold_uncertainty_score":0.019300401},"labels":[],"label_agreement":null},{"id":"W4312115155","doi":"10.1007/s10557-022-07413-0","title":"Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials","year":2022,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma","keywords":"Medicine; Placebo; Adverse effect; Post-hoc analysis; Internal medicine; Confidence interval; Randomized controlled trial; Dosing; Clinical trial; Lipid profile; Cholesterol; Pathology","score_opus":0.00802894109880252,"score_gpt":0.24997182522052372,"score_spread":0.2419428841217212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312115155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89493203,0.08978166,0.0031750354,0.0007557807,0.0011340257,0.003294992,0.0039169677,0.00028576978,0.0027236235],"genre_scores_gemma":[0.9800238,0.011626038,0.0021636095,0.00068864424,0.00061379065,0.001734378,0.0020382432,0.000059128153,0.0010523538],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99386865,0.004335193,0.00064959435,0.00059068424,0.00032517468,0.00023063198],"domain_scores_gemma":[0.9932854,0.0035645587,0.0018725998,0.0005581076,0.00040917392,0.00031003848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011001735,0.0020523123,0.006171261,0.0007375223,0.00025399288,0.0017075017,0.0007164945,0.00095314434,0.0031491495],"category_scores_gemma":[0.009269038,0.00062744453,0.010959799,0.00090096024,0.00056118955,0.0010482356,0.0005704165,0.0017946187,0.00030808712],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85640484,0.00067071157,0.0040759062,0.004745175,0.117380254,0.00006471514,0.00004248771,0.00082203205,0.0016108241,0.00006947193,0.000967752,0.013145848],"study_design_scores_gemma":[0.6840704,0.06278351,0.034294054,0.0006289108,0.21141484,0.00017933831,0.00010136743,0.0020668663,0.001542101,0.00043489266,0.0023774945,0.00010619284],"about_ca_topic_score_codex":0.0005458057,"about_ca_topic_score_gemma":0.0015730155,"teacher_disagreement_score":0.011001735,"about_ca_system_score_codex":0.0006412046,"about_ca_system_score_gemma":0.0010254908,"threshold_uncertainty_score":0.05818343},"labels":[],"label_agreement":null},{"id":"W4365443994","doi":"10.1007/s10557-023-07452-1","title":"Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction","year":2023,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"Amgen","keywords":"Medicine; Myocardial infarction; Guideline; Cholesterol; Internal medicine; Cardiology; Disease; Atherosclerotic cardiovascular disease; Ldl cholesterol; Intensive care medicine; Pathology","score_opus":0.02048169665640739,"score_gpt":0.25906553650527003,"score_spread":0.23858383984886264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365443994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636695,0.01334737,0.0011303851,0.00216749,0.00026577254,0.000111863206,0.0013841303,0.00010619223,0.01781722],"genre_scores_gemma":[0.99569184,0.0016665428,0.0004823893,0.00040123198,0.0003233606,0.000023443918,0.00082112063,0.0000054810116,0.00058466045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901783,0.00032324737,0.00011105231,0.00009583648,0.00022323783,0.00022888425],"domain_scores_gemma":[0.99789065,0.0004327406,0.0009257804,0.00016576868,0.0002368696,0.00034827407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012356015,0.00027067034,0.0011160073,0.0005313605,0.0004137821,0.00054887147,0.00040277213,0.00081993366,0.0015213521],"category_scores_gemma":[0.005232154,0.00014781958,0.0009933246,0.00055683963,0.00013732255,0.00033433244,0.00035049807,0.0012227922,0.00028465985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010539419,0.0014862375,0.8620054,0.00058342575,0.0018516034,0.0015180223,0.00020795465,0.00056138256,0.001958861,0.00073843915,0.005704518,0.11284462],"study_design_scores_gemma":[0.00023924181,0.0010014022,0.99337864,0.00008117869,0.0011304411,0.00088620966,0.000100199206,0.0007912283,0.00023103262,0.00045852558,0.001686167,0.000015683241],"about_ca_topic_score_codex":0.0039053836,"about_ca_topic_score_gemma":0.010738795,"teacher_disagreement_score":0.0039053836,"about_ca_system_score_codex":0.00049999834,"about_ca_system_score_gemma":0.0008428013,"threshold_uncertainty_score":0.007765293},"labels":[],"label_agreement":null},{"id":"W4403873272","doi":"10.1007/s10557-024-07630-9","title":"International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards","year":2024,"lang":"en","type":"editorial","venue":"Cardiovascular Drugs and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Toronto","funders":"","keywords":"Medicine; Obesity; Diabetes mellitus; Gerontology; Family medicine; Internal medicine; Endocrinology","score_opus":0.03723913398797392,"score_gpt":0.3421870963989569,"score_spread":0.304947962410983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403873272","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000124514445,0.0055826716,0.000065627304,0.07817249,0.91547567,0.000012902956,0.000023052251,0.00003372455,0.0006213602],"genre_scores_gemma":[0.00016493104,0.0029548197,0.000078827616,0.060823325,0.93245184,0.00002579771,0.000018656112,0.000030059877,0.0034517501],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9814477,0.0036720352,0.0019234227,0.0019345393,0.0091379555,0.001884319],"domain_scores_gemma":[0.93450755,0.023630798,0.005375701,0.0017032267,0.01791218,0.016870502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022317877,0.0062637823,0.0072690956,0.006468069,0.007877005,0.019949373,0.0069582583,0.06068158,0.02053617],"category_scores_gemma":[0.06866578,0.002855726,0.0059916046,0.003011082,0.005873755,0.01257633,0.0076614944,0.06606409,0.016151214],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017754335,0.0000080306945,0.000015521875,0.00010456718,0.000015420408,0.00004097359,0.0000105718755,0.0000079016445,0.000015976093,0.00020129862,0.9970862,0.0024756365],"study_design_scores_gemma":[0.00019821008,0.000041514537,0.00026080053,0.0010102277,0.00013011027,0.00018989174,0.0000891606,0.00012620911,0.000048404174,0.0018006413,0.99605787,0.00004694318],"about_ca_topic_score_codex":0.0037801997,"about_ca_topic_score_gemma":0.016655672,"teacher_disagreement_score":0.06068158,"about_ca_system_score_codex":0.009049601,"about_ca_system_score_gemma":0.013086918,"threshold_uncertainty_score":0.118029594},"labels":[],"label_agreement":null},{"id":"W4407672429","doi":"10.1007/s10557-025-07679-0","title":"Evaluating the Methodological Rigor and Recommendation Excellence of TAVR Guidelines: Insights from AGREE II and AGREE-REX Instruments","year":2025,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Excellence; Rigour; Medical physics; Engineering ethics; Medical education; Epistemology","score_opus":0.2444062197879339,"score_gpt":0.4876867934298203,"score_spread":0.2432805736418864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407672429","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012728832,0.77171636,0.07342711,0.08763439,0.008101431,0.019009855,0.010799344,0.00049243594,0.01609026],"genre_scores_gemma":[0.34732226,0.23583186,0.28304216,0.05108697,0.0059572,0.061516725,0.0126242805,0.00077601004,0.0018424009],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.20733142,0.5327884,0.1904899,0.014243772,0.05259263,0.0025539643],"domain_scores_gemma":[0.056452904,0.83467174,0.047217406,0.024860715,0.035005495,0.0017917509],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6276298,0.0030014638,0.015834322,0.013478734,0.002731619,0.015022445,0.0093017435,0.009295673,0.0075402404],"category_scores_gemma":[0.88045377,0.0034082117,0.020824278,0.012089673,0.007757067,0.009034638,0.011670796,0.009429793,0.0009302177],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030062308,0.00017069922,0.0186293,0.45445216,0.16213863,0.00018887862,0.007826603,0.0027062544,0.00035768133,0.033903264,0.031879876,0.28474045],"study_design_scores_gemma":[0.0070490744,0.0008312199,0.024233177,0.6278397,0.14385381,0.0004679024,0.0029031492,0.0052597243,0.0010593672,0.09336968,0.09236399,0.00076916296],"about_ca_topic_score_codex":0.010713849,"about_ca_topic_score_gemma":0.017082987,"teacher_disagreement_score":0.37237018,"about_ca_system_score_codex":0.009852541,"about_ca_system_score_gemma":0.041078,"threshold_uncertainty_score":0.45919877},"labels":[],"label_agreement":null},{"id":"W4409119850","doi":"10.1007/s10557-025-07689-y","title":"MOTS-c: Magical Molecule for Diabetic Cardiomyopathy?","year":2025,"lang":"en","type":"editorial","venue":"Cardiovascular Drugs and Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Diabetic cardiomyopathy; Cardiomyopathy; Diabetes mellitus; Internal medicine; Cardiology; Heart failure; Endocrinology","score_opus":0.007850921517154606,"score_gpt":0.24353047994654112,"score_spread":0.2356795584293865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409119850","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004129596,0.028946819,0.00012679417,0.045079857,0.92390007,0.000027084385,0.00004519248,0.000054667365,0.0017781737],"genre_scores_gemma":[0.00037964724,0.010364889,0.00010115545,0.032271136,0.9506901,0.000026971762,0.000025189573,0.00002176291,0.0061191088],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594975,0.0010423043,0.0005668618,0.00036868185,0.0017401163,0.0003320978],"domain_scores_gemma":[0.98935145,0.0045455527,0.0009947036,0.000306736,0.002517929,0.0022836276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008105276,0.00409522,0.00441695,0.0035733993,0.0029864218,0.0065485556,0.0041201296,0.026650576,0.012981062],"category_scores_gemma":[0.01730736,0.0015647723,0.00351282,0.0015014004,0.0024110693,0.00484355,0.0026520642,0.023945412,0.00922689],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072982424,0.000012577533,0.000018400478,0.0003421361,0.00003238483,0.00011701094,0.000009027029,0.00002234829,0.000055246546,0.00035659017,0.98917246,0.009788758],"study_design_scores_gemma":[0.0002478494,0.00009488682,0.00023854706,0.0007699369,0.00014920378,0.00037845844,0.00003225776,0.00018176247,0.00010356109,0.0012233156,0.99655116,0.000029036626],"about_ca_topic_score_codex":0.00167433,"about_ca_topic_score_gemma":0.00577617,"teacher_disagreement_score":0.026650576,"about_ca_system_score_codex":0.003630765,"about_ca_system_score_gemma":0.0027613305,"threshold_uncertainty_score":0.043425977},"labels":[],"label_agreement":null},{"id":"W4409967998","doi":"10.1007/s10557-025-07705-1","title":"Quercetin and Cardiac Fibrosis—Promise or Polyphenolic Placebo?","year":2025,"lang":"en","type":"editorial","venue":"Cardiovascular Drugs and Therapy","topic":"Meat and Animal Product Quality","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"John S. Dunn Foundation","keywords":"Medicine; Quercetin; Polyphenol; Cardiac fibrosis; Placebo; Fibrosis; Pharmacology; Internal medicine; Cardiology; Traditional medicine; Pathology; Antioxidant; Biochemistry; Alternative medicine","score_opus":0.015309443827740857,"score_gpt":0.23426580617470014,"score_spread":0.21895636234695928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409967998","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006829159,0.048690986,0.0001295529,0.053449444,0.89549583,0.000031776715,0.00007992605,0.000053347183,0.0020008392],"genre_scores_gemma":[0.0007533582,0.021090355,0.00015042583,0.052799214,0.9160119,0.00004038834,0.000037247668,0.000023287756,0.009093849],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960871,0.0010867759,0.0006350859,0.00048146257,0.0014815779,0.00022810204],"domain_scores_gemma":[0.987176,0.007854436,0.0007501405,0.00026569364,0.0025800865,0.0013737031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009742465,0.0039992942,0.005449926,0.0024814242,0.0021602407,0.006252179,0.0045235828,0.023520894,0.009944697],"category_scores_gemma":[0.02057138,0.0012874588,0.0032194452,0.0013375016,0.002257656,0.0040325006,0.0011315327,0.021453526,0.0064897295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002896558,0.00003192606,0.000025688541,0.0006381377,0.00009464008,0.00015300415,0.000011641235,0.000020181751,0.000076548014,0.0004971741,0.9877364,0.010425029],"study_design_scores_gemma":[0.000983429,0.00021003291,0.00052771514,0.0014105529,0.00051188405,0.00041762026,0.00007641271,0.00036034625,0.00018731163,0.0022340303,0.9930294,0.000051251678],"about_ca_topic_score_codex":0.002654959,"about_ca_topic_score_gemma":0.0067786574,"teacher_disagreement_score":0.023520894,"about_ca_system_score_codex":0.0030993624,"about_ca_system_score_gemma":0.0025568437,"threshold_uncertainty_score":0.051523685},"labels":[],"label_agreement":null},{"id":"W628479708","doi":"10.1007/s10557-015-6600-y","title":"β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial","year":2015,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université de Montréal; University of Calgary","funders":"","keywords":"Medicine; Cardiology; Hazard ratio; Internal medicine; Angina; Myocardial infarction; Ejection fraction; Stroke (engine); Heart failure; Canadian Cardiovascular Society; Unstable angina; Confidence interval","score_opus":0.030407401783559128,"score_gpt":0.238094498504761,"score_spread":0.20768709672120186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W628479708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98006815,0.014834575,0.00042242845,0.0009700526,0.0003062448,0.00010640566,0.00107091,0.000027536942,0.002193619],"genre_scores_gemma":[0.9931652,0.0031275372,0.00036736752,0.00063864456,0.00060712756,0.00011382002,0.0015340132,0.000014355817,0.00043186586],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99783903,0.0015066795,0.00014243415,0.00023547761,0.00015131326,0.00012512707],"domain_scores_gemma":[0.99594635,0.001759115,0.001324243,0.0004544681,0.00012179322,0.00039401854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004264896,0.000627615,0.0022174213,0.00018850119,0.00023663728,0.0014430027,0.0005877449,0.0009905904,0.0020825744],"category_scores_gemma":[0.0063825664,0.00026196393,0.002479691,0.00033777457,0.0006092704,0.00061102747,0.0005624118,0.0013576625,0.00028207066],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8235072,0.0016539682,0.106355526,0.0021796182,0.029161839,0.00040599838,0.00016667806,0.0009715363,0.0031937324,0.0009056163,0.0029932219,0.028505169],"study_design_scores_gemma":[0.41060185,0.085734665,0.42248008,0.0009879374,0.05960355,0.0012922365,0.000310102,0.0032208073,0.0017971991,0.0025735921,0.011214884,0.0001831786],"about_ca_topic_score_codex":0.00032848437,"about_ca_topic_score_gemma":0.0006709158,"teacher_disagreement_score":0.004264896,"about_ca_system_score_codex":0.0002397655,"about_ca_system_score_gemma":0.00028495962,"threshold_uncertainty_score":0.022555172},"labels":[],"label_agreement":null},{"id":"W79204675","doi":"10.1023/a:1015315531157","title":"Effects of Quinapril on Myocardial Function, Ventricular Remodeling and Cardiac Cytokine Expression in Congestive Heart Failure in the Rat","year":2002,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital; Université de Montréal; Montreal Heart Institute","funders":"University of Toronto; Medical Research Council Canada; University Health Network; Heart and Stroke Foundation of Canada","keywords":"Quinapril; Medicine; Heart failure; Angiotensin-converting enzyme; Myocardial infarction; Cytokine; Internal medicine; ACE inhibitor; Tumor necrosis factor alpha; Hemodynamics; Cardiology; Blood pressure","score_opus":0.008975000075039841,"score_gpt":0.20911988891288225,"score_spread":0.2001448888378424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W79204675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965487,0.0014799354,0.00064900477,0.00028510552,0.00010770234,0.000026124291,0.0003937188,0.000052972948,0.0004568316],"genre_scores_gemma":[0.9943059,0.0015020707,0.00089130347,0.00017913674,0.00011106836,0.00007830622,0.0005034815,0.000022974787,0.002405775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971133,0.00006923113,0.000018622131,0.00005290542,0.000035997462,0.000111968104],"domain_scores_gemma":[0.9989568,0.00022610636,0.0002275531,0.00012236531,0.0000878243,0.00037938924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000501516,0.0007527328,0.00095008704,0.0003967024,0.00039408094,0.0005164544,0.00038665457,0.0007267316,0.0012209453],"category_scores_gemma":[0.0006017181,0.00042937233,0.00049439585,0.00027051294,0.0010513134,0.0009132531,0.00022835357,0.0017529874,0.00020679242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09255582,0.002820334,0.002244748,0.0002588468,0.0001372668,0.00055090827,0.00020471973,0.0007188625,0.88638216,0.00038506184,0.00039314455,0.0133482525],"study_design_scores_gemma":[0.0041097607,0.044092182,0.04512973,0.000036117555,0.00042079113,0.00030501536,0.00059573085,0.003533248,0.8992538,0.00048410182,0.0019320955,0.00010747087],"about_ca_topic_score_codex":0.0013658922,"about_ca_topic_score_gemma":0.0020707154,"teacher_disagreement_score":0.0013658922,"about_ca_system_score_codex":0.0003700282,"about_ca_system_score_gemma":0.00047453344,"threshold_uncertainty_score":0.004084468},"labels":[],"label_agreement":null},{"id":"W840416514","doi":"10.1007/s10557-015-6603-8","title":"The Role of 17β-Estradiol in Myocardial Hypertrophy in Females in the Presence and Absence of Hypertension","year":2015,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick; Canada Research Chairs; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Myocardial hypertrophy; Endocrinology; Cardiology; Muscle hypertrophy; Cardiac hypertrophy; Left ventricular hypertrophy; Blood pressure","score_opus":0.045241630800272804,"score_gpt":0.2712441880027153,"score_spread":0.22600255720244253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W840416514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804083,0.015565518,0.00013784788,0.00056201423,0.000063460386,0.0000074140535,0.00018156624,0.000005565923,0.0030683046],"genre_scores_gemma":[0.99438274,0.004382654,0.00009553349,0.000097272794,0.00022474032,0.0000030282836,0.00007279874,0.000002862471,0.00073838443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998976,0.000037823986,0.0000074319205,0.000012956767,0.000023067467,0.00002111322],"domain_scores_gemma":[0.99957365,0.00015897669,0.00013695723,0.000020954574,0.000031716325,0.00007780692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027200804,0.00018824577,0.00033353275,0.00037510676,0.00019419816,0.00037264868,0.000161823,0.00029550993,0.0015084235],"category_scores_gemma":[0.0010439348,0.0001994954,0.00023657232,0.00022344258,0.0002615791,0.0002795316,0.00017338239,0.00044236117,0.00015560428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00634921,0.00029248482,0.9322168,0.00015414809,0.0002431052,0.002071862,0.00024772115,0.00010899974,0.013289243,0.00027506344,0.00039564286,0.04435584],"study_design_scores_gemma":[0.000022479475,0.000318583,0.9977697,0.000013656731,0.00007327507,0.00084519567,0.00015584858,0.0000667936,0.0002752309,0.00006847427,0.0003877016,0.0000030996523],"about_ca_topic_score_codex":0.0011608873,"about_ca_topic_score_gemma":0.0017958491,"teacher_disagreement_score":0.0015084235,"about_ca_system_score_codex":0.00012693017,"about_ca_system_score_gemma":0.00016415867,"threshold_uncertainty_score":0.005046129},"labels":[],"label_agreement":null},{"id":"W879593102","doi":"10.1007/s10557-015-6608-3","title":"Suppression of Ventricular Arrhythmias After Myocardial Infarction by AT1 Receptor Blockade: Role of the AT2 Receptor and Casein Kinase 2/Kir2.1 Pathway","year":2015,"lang":"en","type":"letter","venue":"Cardiovascular Drugs and Therapy","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Ventricular fibrillation; Internal medicine; Cardiology; Ventricular tachycardia; Myocardial infarction; Angiotensin II receptor type 1; Angiotensin II; Angiotensin receptor; Receptor","score_opus":0.005215014693345902,"score_gpt":0.19712903744748428,"score_spread":0.19191402275413838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W879593102","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025849912,0.014954953,0.001290584,0.928934,0.013610032,0.00006588585,0.00016944631,0.00018813682,0.014937025],"genre_scores_gemma":[0.24149981,0.01728451,0.002644903,0.6133115,0.10756987,0.0002185227,0.00021690117,0.00005416528,0.017199706],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996063,0.00013327757,0.00006792185,0.000035007317,0.00009264209,0.00006497257],"domain_scores_gemma":[0.99902546,0.0005929676,0.00008722333,0.00004825597,0.000115970106,0.00013016257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065000606,0.00042654216,0.0012969959,0.0001770636,0.00069915625,0.00097524497,0.00067657203,0.011498113,0.0019197619],"category_scores_gemma":[0.0044067837,0.00017166956,0.0008593038,0.00019857746,0.0008163226,0.001036261,0.0003402973,0.00873872,0.0022312915],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024238585,0.00059832435,0.007715442,0.00053062866,0.00020511028,0.18954301,0.00041826116,0.0008381577,0.010302651,0.0115233185,0.5809724,0.1949289],"study_design_scores_gemma":[0.00392935,0.002619432,0.024728898,0.00096928736,0.0003187111,0.25536135,0.00064306,0.007485199,0.00689657,0.04326157,0.6535423,0.0002443736],"about_ca_topic_score_codex":0.0007510555,"about_ca_topic_score_gemma":0.0016276552,"teacher_disagreement_score":0.011498113,"about_ca_system_score_codex":0.0014172271,"about_ca_system_score_gemma":0.0006342439,"threshold_uncertainty_score":0.0102828145},"labels":[],"label_agreement":null}]}